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Abstract 
 
The evaluation of the immune responses in peripheral blood and at the site of disease of people 
with differential outcomes following M.tb exposure will lead to the discovery of host biomarkers 
that will increase our understanding of the protective and non-protective immune responses 
against the bacterium.  
 
The main study consisted of a number of pilot studies and the objectives of the studies were:  
(1) To determine the background and stimulated whole blood cytokine profiles of children and 
adults of the community;  
(2) to establish biomarker profiles in whole blood of children with different M.tb infection 
phenotypes;  
(3) to investigate the anti-mycobacterial whole blood immune responses in HIV infected and 
uninfected children;  
(4) and to investigate the role of the innate immune system during human tuberculosis disease.  
 
The study designs were as follow: 
(1) Adults and children were enrolled in order to determine cytokine profiles in the community. 
Whole blood was stimulated with BCG and ESAT-6 or left unstimulated. Eighteen cytokines were 
measured in supernatants of each condition. Progression to active tuberculosis in the years after 
study participation was assessed by searching for patient entries in the tuberculosis register. 
(2) Children with known tuberculosis exposure in their households and with M.tb infection as 
assessed through interferon-γ release assays, children with exposure but no infection and a 
control group with no exposure and no infection were investigated. Whole blood was stimulated 
in QuantiFeron tubes overnight and 21 cytokines were measured in antigen stimulated and 
unstimulated supernatants by multiplex cytokine arrays.  
(3) HIV infected and uninfected children were enrolled in a hospital based study. Whole blood 
interferon-γ responses against specific mycobacterial antigens were investigated in a diluted 7 
day whole blood assay and compared to QuantiFeron supernatants from the same participants. 
(4) Tuberculosis diseased adults were enrolled before the onset of treatment and innate and 
adaptive cell populations were investigated upon start of treatment and at treatment end. In 
addition, pleural effusion fluid was collected from tuberculosis and cancer patients and innate cell 
populations further investigated. 
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The studies were performed in Cape Town, South Africa and included Tygerberg Academic 
Hospital and the surrounding neighbourhoods of Ravensmead, Uitsig and Elsies River. 
 
The main findings of the studies included: 
(1) We showed age related cytokine differences in our study community. Tuberculosis 
progressors had significantly higher levels of IL-10 in the unstimulated sample several years 
before the onset of tuberculosis disease. 
(2) Cytokines that distinguished best between children with tuberculosis infection and no 
infections were all cytokines that correlated with interferon-γ (interferon-γ was used to make the 
classification of M.tb infected and uninfected). Higher IL-1β and lower IL-17 levels in children with 
tuberculosis exposure without subsequent M.tb infection compared to children with no exposure 
were shown. 
(3) HIV infected children showed better responses after 7 day whole blood antigen stimulation 
compared to the overnight stimulation in QuantiFeron tubes. TB10.4 stimulation in HIV infected 
TST positive children gave higher interferon-γ responses than ESAT-6 and CFP-10. 
(4) The presence of myeloid derived suppressor cells is shown during tuberculosis disease 
circulating in peripheral blood. Upon treatment a decrease in the population is observed. No 
differences were seen in the myeloid derived suppressor cell frequencies between tuberculosis 
and cancer patients, however significantly lower frequencies were seen in healthy controls. 
  
The immune response against M.tb is complex and interactions between the different cell types 
are essential to control and fight infection and disease. In this thesis we presented new 
biomarkers that play important roles during different stages of M.tb pathogenesis from exposure 
to infection and even during disease. These may shed light on mechanisms of protection against 
M.tb, relevant to development of tuberculosis diagnostics and vaccine strategies. Combinations 
of multiple biomarkers including cytokines and chemokines and cell subsets are required to 
characterize biosignatures relevant to the diagnosis of tuberculosis infection and disease.  
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Opsomming 
Deur die immuunreaksie te ondersoek, in heelbloed en in die setel van infeksie, in mense met 
verskillende uitkomste van M.tb blootstelling sal lei tot die ontdekking van biologiese merkers en 
sal bydra tot ons begrip van die beskermde en nie-beskermde immuunreaksies teen die 
bakterium. 
 
Die hoofstudie het bestaan uit ‘n aantal loodsstudies en die doel van die studies was:  
(1) Om die sitokienprofiele in gestimuleerde heelbloed, asook agtergrond waardes, van kinders en 
volwassenes te bepaal, in die gemeenskap; 
(2) om die profiele van biologiese merkers in heelbloed van kinders met verskillende M.tb infeksie 
fenotipes te bepaal; 
(3) om die anti-mykobakteriële immuunreaksies in heelbloed by MIV geïnfekteerde en nie-
geïnfekteerde kinders te bepaal; 
 (4) om ondersoek in te stel na die doel van die aangebore immuunsisteem tydens tuberkulose 
siekte. 
 
Die studie ontwerpe was soos volg: 
(1) Volwassenes en kinders het deelgeneem aan die ondersoek van sitokienprofiele in die 
gemeenskap. Heelbloed is gestimuleer met BCG en ESAT-6 of is ongestimuleerd gelaat. Agtien 
sitokiene is gemeet in die bo-stand verkry van elke kondisie. Mense wat aktiewe tuberkulose 
siekte in die jare na die studie ontwikkel het, is geïdentifiseer deur die pastiëntinligting in die 
tuberkulose-register. 
(2) Kinders met gedokumenteerde huishoudelike tuberkulose blootstelling en met M.tb infeksie, 
soos bepaal deur vrygelate interferon-ã toetse, kinders met blootstelling maar geen infeksie en ‘n 
kontrole groep met geen blootstelling en geen infeksie, is ondersoek. Heelbloed is gestimuleer in 
die QuantiFeron buise oornag en 21 sitokiene is gemeet in die antigeen gestimuleerde en 
ongestimuleerde bostande deur die multiplex sitokienpaneel.  
(3) MIV geïnfekteerde en nie-geïnfekteerde kinders het deelgeneem aan ‘n hospitaal baseerde 
studie. 
Heelbloed interferon-ã reaksies teen spesifieke mykobakteriële antigene is bestudeer in ‘n 
verdunde 7 dag heelbloed toets en vergelyk met die QuantiFeron bostande van dieselfde 
deelnemers. 
 (4) Siek tuberkulose volwassenes wat nie op behandeling is nie, het deelgeneem. Die aangebore 
en verworwe selpopulasies is bepaal aan die begin van behandeling asook voor die einde van 
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behandeling. Verder is pluralevog van tuberkulose en kanker pastiënte bestudeer vir aangebore 
selpopulasies. 
 
Die studies is uitgevoer in Kaapstad, Suid-Afrika en sluit in Tygerberg Akademiese Hospitaal en die 
gemeenskappe van Ravensmead, Uitsig en Elsiesrivier. 
 
Die hoofbevindinge van die studies sluit in: 
(1) Ons het gewys dat daar ouderdomsverwante sitokien verskille in die studie gemeenskap is. 
Mense wat tuberkulose siekte ontwikkel het, het beduidende hoër vlakke van IL-10 in die 
ongestimuleerde monsters getoon ‘n paar jaar voor die begin van die siekte. 
(2) Sitokiene wat die beste onderskeiding gewys het tussen infeksie en geen infeksie was 
sitokiene wat ook korrelasie getoon het met interferon-ã (interferon-ã is gebruik om die 
klassifikasie te maak van M.tb infeksie of geen infeksie). Hoër IL-1â en laer IL-17 vlakke in kinders 
met tuberkulose blootstelling en sonder M.tb infeksie, is gewys wanneer dit vergelyk is met 
kinders sonder blootsteling. 
(3) MIV geïfekteerde kinders het beter reaksies getoon na 7 dag heelbloed antigeen stimulasie as 
met die oornag stimulasie in QuantiFeron buise. TB10.4 stimulasie in MIV geïnfekteerde TST 
positiewe kinders het hoër interferon-ã reaksies getoon as na stimulasie met ESAT-6 en CFP-10. 
(4) Die teenwoordigheid van miloïed afgeleide onderdrukkende selle in heelbloed, is getoon 
tydens tuberkulose siekte. Na behandeling is ‘n afname in die populasie gesien. Geen verskille is 
gesien in die aantal miloïed afgeleide onderdrukkende selle tussen tuberkulose en kanker 
pastiënte nie, alhoewel beduidende laer getalle is waargeneem in gesonde kontrole deelnemers. 
  
Die immuunreaksie teen M.tb is kompleks en interaksies tussen die verskillende seltipes is 
belangrik om infeksie en siekte te kontroleer en te beveg. In die tesis het ons nuwe biologiese 
merkers geïdentifiseer wat belangrike funksies het, tydens die verskillende stadiums van M.tb 
patogenesiteit, van blootstelling tot infeksie asook tydens siekte. Dit kan gebruik word as 
biologiese merkers betrokke by die immuunreaksie teen M.tb en sal bydra tot die diagnose van 
tuberkulose infeksie en siekte. 
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“And though every single human in the stands or in the commentary boxes was at a 
complete loss for words, the man who in his life had uttered fewer words than any of 
them knew exactly what to say.  
 
 
That'll do, pig. That'll do.“ 
 
 
 
 
 
 
Babe (2005) 
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Chapter 1 
The immune responses against Mycobacterium tuberculosis 
 
Introduction  
This review will give a brief overview of the immune response to tuberculosis with particular 
focus on the cell types studied during the thesis work. 
Tuberculosis  
During the industrial revolution, pulmonary tuberculosis was one of the main causes of death. 
However, during the early 19th Century tuberculosis was romanticized amongst the middle class 
(Rosner and Markowitz, 1991), but for the working class the disease was much more threatening. 
Life expectancy was low and the infant mortality rate high. Within one year (1838-1839), more 
than 60 000 people in England and Wales were killed by tuberculosis. 
 
During the 1890’s many countries set out to educate people on the prevention of tuberculosis. 
The people were educated on healthy life style and living conditions. The United Kingdom 
followed suit and in 1902 the International Union against Tuberculosis was founded, based in 
Berlin. After the First World War the office reopened in Geneva in 1920 (Croft and Croft, 2005). 
The Union encouraged tuberculosis control throughout Europe. Most patients received medical 
care in sanatoriums but no real progress was made. It was only after governments took steps to 
improve housing and poverty that the number of tuberculosis cases was reduced. With the 
discovery of new antibiotics between 1945 and 1960 many more people were cured. 
 
It was towards the latter part of the previous century that a re-emergence of tuberculosis was 
seen and again it is the poor who were the victims (Comas and Gagneux, 2009). Today more than 
ninety percent of tuberculosis cases occur in developing countries (Tuberculosis Alliance). 
Tuberculosis is prevalent again in densely populated areas often without basic services. The 
disease exacerbates poverty and this in turn increases the likelihood of others to contract 
tuberculosis. 
 
Stellenbosch University  http://scholar.sun.ac.za
2 
 
It has been long after the discovery of Mycobacterium tuberculosis and it remains one of the most 
common infectious causes of death around the world. In addition, with humans as the only 
natural hosts for M. tuberculosis, this bacterium also has the ability to establish latent infections 
and has spread to nearly a third of the world’s population (WHO, 2008). 
M. tuberculosis 
M. tuberculosis (M.tb) belongs to the genus Mycobacterium that includes around 50 more 
species, often referred to as non-tuberculous mycobacteria or NTMs. Tuberculosis is defined as a 
disease caused by members of the M.tb complex. This complex includes M. tuberculosis, M. bovis, 
M. africanum, M. microti and M. canettii (Alexander et al., 2010; Gutierrez et al., 2005).  
 
For the diagnosis of tuberculosis disease it is relied on M.tb cultures in combination with chest X-
rays of diseased individuals; however for the diagnosis of infection other methods are employed. 
The tuberculin skin test (TST) with purified protein derivative (PPD, soluble antigens derived from 
M.tb), illicit a classic delayed type hypersensitivity response and has been used for years to 
identify M.tb infection. The TST has been the subject of controversy, largely due to its lack of 
specificity in those who have been vaccinated with bacille Calmette-Guérin (BCG) or those 
exposed to possible cross-reactive NTM. False-positive results can lead to unnecessary treatment, 
(Vanhoof et al., 2003). In addition, patients undergoing immunosuppressive therapy more often 
display negative TST results compared with general population (Ponce de León et al., 2005). 
Another major disadvantage is that the TST requires two visits to the clinic. Many countries use 
the BCG vaccine as part of their tuberculosis control programmes. According to the WHO (2008), 
BCG is the most commonly used vaccine worldwide and in South Africa all children are routinely 
vaccinated with BCG.  
 
More recently, other promising antigens that have been identified found predominantly in 
bacterial cell lysates or culture filtrates (or both). These antigens include α-crystallin (Rv2031c, 
HspX, Geluk et al., 2007), early secreted antigenic target, ESAT-6 (Rv3875, Demissie et al., 2006), 
culture filtrate protein-10, CFP10 (Rv3874, Skjøt et al., 2000) and TB10.4 (Rv0288, Skjøt et al., 
2002) some of which are being tested as potential tuberculosis vaccine candidates.  
 
TB10.4 is expressed by both M.tb and BCG and is a promising vaccine candidate against M.tb 
infection. The vaccine is part of a fusion protein subunit vaccine HyVac4 based on TB10.4 and 
Ag85B that is currently in clinical trials (Dietrich et al., 2005). ESAT6 is a T cell stimulatory antigen 
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and is recognised by IFN-γ secreting T cells that are present in greater numbers in patients with 
active disease than in those who are uninfected (Ravn et al., 2005). ESAT6- and CFP10-induced 
IFN-γ responses have been shown to be useful in discriminating infected individuals from healthy 
controls (Brock et al., 2001). The importance of these recombinant antigens is in their immune 
recognition by T cells specific to infected individuals. Work by Demissie et al. (2006) have shown 
that immune responses to ESAT6 are more likely to be associated with active infection and that of 
α-crystallin might be a better marker of latency in patients with tuberculosis. Studies have shown 
that ESAT-6/CFP-10 is more specific than PPD in detecting latent tuberculosis infection (Lalvani et 
al., 2001; Doherty et al., 2002). Therefore, ESAT-6 and CFP10 have been used for the 
development of commercial assays to detect M.tb infection 
 
The recently introduced commercial interferon gamma (IFN-γ) release assays (IGRA) 
QuantiFERON-TB Gold In-Tube (QFT; Cellestis, Victoria, Australia) and T-Spot.TB (Oxford 
Immunotec, Oxford, United Kingdom) utilise the antigens ESAT-6 and CFP-10, which are present 
in M.tb but absent from most NTM and BCG. A third antigen, TB7.7, has been included in the QFT 
test. TB7.7 (Rv2654) has been shown to be 100 % specific in low risk tuberculosis patients, 
however only 30 % sensitivity is recorded for patients with active tuberculosis (Rothel, 2006). The 
IGRAs appear to be as sensitive as the TST in detecting latent M.tb infection (Pai, 2006) and have 
good specificity that seems unaffected by BCG vaccinations. However, there is no ‘gold standard’ 
for latent M.tb infection. 
Host immune responses 
The initial stages of infection consist of inhaled bacteria being phagocytosed by alveolar 
macrophages that in turn lead to the recruitment of more immune cells and the onset of 
granuloma formation (Peyron et al., 2008). The granuloma consists of a mass of cells including 
macrophages that differentiates into special cell types including foamy macrophages (Peyron et 
al., 2008; Russell et al., 2010). As previously stated M.tb can enter a period of latency in the 
granuloma that can last for years, but only one in ten individuals in this infected population 
develops active disease (WHO, 2008). It is well known that during this time infected persons have 
a positive TST and IGRA aiding in the detection of latent infection. Reactivation of M.tb, the 
progression from infection to disease, is increased by immunosuppressive triggers. These triggers 
can include other concurrent infections like HIV infection (Flynn & Chan, 2001); 
immunosuppressive therapies like tumour necrosis factor (TNF) neutralization therapy for other 
Stellenbosch University  http://scholar.sun.ac.za
4 
 
diseases (Solovic et al., 2010); diseases like diabetes (Perez-Gusman et al, 2000); and even old age 
(Horsburgh et al, 2010).  
 
Apart from causing disease, helminths also affects the incidence and progression of M.tb by 
exerting immune modulatory effects like the induction of a T helper2 immune response. Research 
has shown that chronic helminth infection may affect the ability of the host to control 
mycobacterial infections (Babu et al., 2009; Elias et al., 2006, 2008; Tristão-Sá et al., 2002; Diniz et 
al., 2001). Helminth induced immune modulation may therefore have important consequences 
for co-infections since helminths are prevalent in most areas where tuberculosis is a big health 
concern. However, the exact environmental conditions that influence the progression to 
tuberculosis disease in the host remain to be determined. However, a recent study showed that 
the foamy macrophages seem to be a key participant in both supporting persistent bacteria and 
contributing to the tissue pathology that leads to the release of bacilli (Russell et al., 2009; 2010) 
adding to our current knowledge. 
Innate responses 
The innate response contributes to host immune responses against M.tb. When M.tb enters the 
lung, factors at epithelial surfaces may already interfere with mycobacterial invasion. Consequent 
innate immune responses may decrease the inoculum size during the initial infection and may 
lead to a T helper 1 (Th1) immune responses downstream. During latent infection, innate 
mechanisms probably work as the effector arm of T cell mediated protective immunity to contain 
M.tb (Korbel et al., 2008). During reactivation and active tuberculosis disease the function of the 
innate immune responses is still not entirely clear. One explanation could be that the innate 
immune response may either be ineffective at the time of reactivation and disease due to 
inadequate signals from adaptive immune response (Korbel et al., 2008); or even promote 
immunopathology when not regulated. The innate immune response is very important in the 
early recognition of M.tb (Balboa et al., 2010) and subsequent triggering of a pro-inflammatory 
response to invading microorganism.  
 
The innate cells include antigen presenting dendritic cells (DCs), cytotoxic natural killer (NK) cells, 
phagocytic macrophage, granulocytes and γδ T lymphocytes (Holtmeier & Kabelitz, 2005), some 
of which will be discussed later in this chapter. These cells work in conjunction with each other 
and communicate with the help of cytokines, chemokines and direct contact between cells. 
Cytokines and chemokines secreted by innate immune cells play a crucial part in the host defense 
against M.tb (Russell, 2007) by inducing further activation and cytokine production in a 
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complex process of regulation and cross-regulation. This cytokine network plays a crucial role in 
the inflammatory response and the outcome of mycobacterial infections. 
 
Some of the cytokines important in the innate response to M.tb infection are indicated in Figure 1 
and shortly discussed below. TNF-α, a major pro-inflammatory cytokine, is produced by 
monocytes, macrophages (Mootoo et al., 2009), and DCs upon M.tb recognition. TNF-α plays a 
key role in granuloma formation (Toossi et al., 2000) and induces macrophage activation. TNF-α 
has a crucial role in protective immunity against M.tb infection. Firstly, it was confirmed in 
tuberculosis patients where TNF-α is present at the site of disease (Fenhalls et al., 2000) and 
secondly, it has been shown that TNF receptor deficient mice (Ehlers et al., 2000) developed M.tb 
infection. 
 
IL-1β, another pro-inflammatory cytokine involved in the host response to M.tb. IL-1β is mainly 
produced by monocytes, macrophages, and DCs (TeKippe et al., 2010; Roach et al., 1993). In 
tuberculosis patients, IL-1β is highly expressed (Schauf et al., 1993) and present at the site of 
disease (TeKippe et al., 2010). Mice studies have confirm the important role of IL-1β in 
tuberculosis. IL-1R-deficient mice display an increased mycobacterial growth after infection with 
M.tb (Juffermans et al., 1998). 
 
 
 
Figure 1: Inflammatory response upon immune recognition of M.tb by macrophages and 
dendritic cells. Cytokines that play a role is indicated in italics. Adapted from Van Crevel et al., 
2002. 
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IL-12 acts as a regulatory cytokine which connects the innate and adaptive immune response to 
M.tb (as reviewed by Trinchieri, 2003) and is also an important cytokine in the host defense 
against M.tb.  IL-12 is known to be produced after the phagocytosis of M.tb (Ladel et al., 1997). In 
tuberculosis, IL-12 has been detected in lung infiltrates (Taha et al., 1999), in pleurisy (Budak et 
al., 2008) and in granulomas (Bergaron et al., 1997). IL-12 has a crucial role in IFN-γ production 
(Vankayalapati et al., 2003). 
 
The effects of pro-inflammatory cytokines can be inhibited by anti-infammatory cytokines. IL-6 is 
a cytokine that has both pro- and anti-inflammatory properties (Van Heyningen, 1997). It is 
produced early during mycobacterial infection and at the site of infection (Correia et al., 2009). IL-
6 can also be harmful during infection, as it has been shown to inhibit the production of TNF-α 
and IL-1β (Schindler et al., 1990).  
 
Dendritic cells (DC)  
Dendritic cells play a central role in the initiation of the immune response against M.tb (Balboa et 
al., 2010). Upon M.tb infection pattern recognition receptors (PRRs) such as the toll-like receptors 
(TLRs) recognize specific chemical signatures found in M.tb. Once DCs have a presentable antigen, 
they become activated into mature dendritic cells and begin to migrate to the lymph node 
(Banchereau & Steinman, 1998). The initial interaction between DCs and naive T cells and the 
surrounding cytokine environment influence the quality of immune response. DCs have been sub 
divided into myeloid DCs (mDCs) and plasmacytoid DC (pDCs). mDCs originate from a myeloid 
precursor, express CD11c (identified by cell surface expression of HLA-DR and CD11c and absence 
of CD123) amongst other markers and secrete IL-12 that lead to a T-helper 1(Th1) type immune 
response. mDCs are the biggest population and are found in blood, tissue, and lymph nodes 
(Mendelson et al., 2006). pDCs originate from a lymphoid precursor and express CD123 
(identified by cell surface expression of HLA-DR and CD123 and absence of CD11c) and secrete 
interferon (IFN)-α and induce a Th2 type responses and play a role in the immune response to 
viral infections (Siegal et al., 1999). 
However, subsequent studies suggest that during inflammation and viral infection, pDCs are also 
able to drive a Th1 response, whereas mDCs may be influenced by cytokines like IL-4 and IL-10 to 
stimulate a Th2 response (Kwadowaki et al., 2000; Cella et al., 2000). Therefore, the in vivo 
mechanisms by which dendritic cells control the Th1/Th2 balance are more complex than 
previously thought and may depend on various factors such as the cytokine microenvironment 
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and the pathogen to which DCs are exposed (Moser et al., 2000). Interestingly, it is known that 
different microbial components induce mDCs to produce different levels of IL-12, which leads to 
diverse types of immune responses appropriate to eliminate pathogens (Kadowaki, 2007). 
The study of the role of DCs during tuberculosis disease is held back by various factors as 
discussed by Mendelson et al. (2006) and included low cell frequencies during disease. Any 
decline in the ability of myeloid DCs to undergo maturation and to produce IL-12 may result in 
impaired stimulation of Th1 immunity (Mendelson et al., 2006) which is vital for the control of 
M.tb infection and disease. Taken together, multiple factors, including Th1 and/or Th2 signals 
from DC subsets, may dictate the quality of T cell responses (Ito et al., 2005) during active 
tuberculosis disease. 
Myeloid derived suppressor cells (MDSCs) 
MDSCs have recently been described as the myeloid cells with immune suppressive activity during 
cancer and other diseases. This population consists of immature myeloid derived cells that 
include monocytes, dendritic cells and granulocytes. Myeloid precursor cells originate in the bone 
marrow upon which they migrate as an immature population to the periphery were they mature 
into macrophages, dendritic cells or neutrophils. Under pathological processes like inflammation, 
infections and tumors these immature cells differentiate into MDSCs. The MDSCs produce 
immune suppressive factors like arginase I and inducible nitric oxidase synthase initiating the 
release of nitric oxide and reactive oxygen species that plays a role in programmed cell death and 
other immunosuppressive mechanisms (Ribechini et al., 2010).  
Most of the current information on the role of MDSCs in immune responses has come from 
studies on cancer. However, MDSCs also regulate immune responses during bacterial and other 
infections, inflammation, traumatic stress and sepsis (as reviewed by Gabrilovich and Nagaraj, 
2009). In addition, MDSCs were also observed in mice primed with M.tb in the form of complete 
Freund’s adjuvant (Zhu et al., 2007). Still no evidence exists to show the presence of this cell 
population during tuberculosis disease in humans.  
In humans, MDSCs are most commonly defined as cells that express the myeloid marker CD33 but 
lack the expression of markers of mature myeloid and lymphoid cells and the MHC class II 
molecule (HLA-DR) (Corzo et al., 2009 ). Several other surface molecules have also been used to 
identify additional subsets of suppressive MDSCs, including CD80, CD115 (macrophage colony 
stimulating factor receptor) or CD124 (IL-4 receptor chain) (Schmid & Varner, 2010). Yang et al. 
(2010) reported that expression of CD80 is involved in the immunosuppressive activities of 
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MDSCs. Ribechini et al. (2010) showed that in whole blood of cancer patients there are two 
subpopulations functionally able to suppress the immune response, CD14+ monocytes and CD15+ 
polymorphonuclear cells. 
All current data suggest that MDSCs are a group of phenotypically heterogeneous myeloid cells 
that have common biological activity (as reviewed by Gabrilovich & Nagaraj, 2009; Van 
Ginderachter et al., 2010). MDSCs exhibit flexibility of maturation, differentiation and activation 
in response to the cytokine microenvironment and pathogen-derived triggers to which they are 
exposed as for other myeloid cell types. Hence, their expansion, phenotype and mechanism of 
suppression can vary depending on the range of host and pathogen derived factors they 
encounter (Van Ginderachter et al., 2010). During cancer, expansion and activation of this 
population would lead to immunosuppressive MDSCs (Almand et al., 2001; Gallina et al., 2006). In 
addition, it has been shown that during chronic helminth infections, the MDSCs can mediate the 
suppressive function (Goni et al., 2002; Brys et al., 2005). However, the presence of MDSCs at the 
site of disease, as identified with the current cell markers available to us, does not necessarily 
mean that these cells are immunosuppressive cells. Instead, these cells can be in an immature 
state and will still mature into DCs or macrophages upon the correct signal. 
Natural killer cells (NK cells) 
NK cells are effector cells of the innate immune system and are essential as first line defence 
against invading M.tb. Development of NK cells takes place in the bone marrow from where 
mature NK cells move to peripheral blood. NK cells present in secondary lymphoid organs are 
activated by T cell cytokines (Barcelos et al., 2008) therefore, it can be seen as a potential link 
between adaptive and innate immunity (Fehniger, 2003). Mature NK cells are characterized by 
granules, which include granzymes and perforin, and are capable of rapidly producing IFN-γ and 
other cytokines. Killer cell immunoglobulin like receptors (KIRs), are a family of cell surface 
proteins found on NK cells (Vilches & Parham, 2002). They regulate the killing function of these 
cells by interacting with MHC class I molecules, which are expressed on all cell types. This 
interaction allows them to detect cells that have a characteristic low level of MHC class I on their 
surface (Vilches & Parham, 2002). 
 
NK cells are a distinct subpopulation of lymphocytes defined as CD3- CD16+ and/or CD56+ 
(Robertson et al., 1990). In the peripheral blood, most NK cells are mature NK cells (CD3- CD16+ 
CD56+) (Barcelos et al., 2006; Barcelos et al., 2008) and little is known about the biological 
properties of the other NK cell subsets during tuberculosis infection. However, it is known that NK 
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cells play a protective role during tuberculosis and reduced activity of NK cells has been reported 
in diseased tuberculosis patients (Nirmala et al., 2001). 
Natural killer T cells (NKT cells) 
NKT cells are narrowly defined as a T cell lineage expressing NK receptors that include NK1.1 
(Bendelac et al., 2007) and a semi invariant CD1d restricted αβ T cell receptor. Phenotypic studies 
have demonstrated that NKT cells are distinct from T cells in that they express CD56, a NK cell 
marker as mentioned previously (Barcelos et al., 2008). NKT cells play an innate protective 
response against intracellular pathogens like M.tb and are under the control of the antigen 
presenting cells and soluble factors in the microenvironment (Barcelos et al., 2008). NKT cells has 
been shown to produce large quantities of Th1 (IFN-γ) and Th2 (IL-4) cytokines upon activation. 
Previous studies proposed to use NKT cell frequencies during tuberculosis disease as a prognostic 
marker for disease activity (Zahran et al., 2006) as NKT cells were shown to stop responding in 
mice during the course of BCG infection (Chiba et al., 2008).  
Invariant natural killer T cells (iNKT cells) 
iNKT cells are a subgroup of NKT cells that recognise glycolipid antigens presented by the antigen 
presenting molecule CD1d. Almost all of the CD1d restricted NKT cells display an invariant TCR 
repertoire, consisting of an invariant Vα24 chain paired with a semi invariant Vβ11 chain (Wilson 
& Delovitch, 2003; Yu & Porcelli, 2005). iNKT, like NKT cells, have the ability to regulate the innate 
and adaptive immune systems by rapid activation and the ability to release large amounts of Th1 
and/or Th2 cytokines and perforin and granzymes (Kaer, 2007). Unfortunately, there is much less 
information on the role of iNKT cells during human immune responses. Some recent studies have 
shown that iNKT cells are activated during M.tb infection (Montoya et al., 2008). 
Adaptive responses 
The innate and adaptive immune responses are closely connected. Macrophages and dendritic 
cells, the primary cell types involved in the innate immune response to M.tb (Balboa et al., 2010), 
play an important role in the onset of the adaptive response. Two different lymphocytes play a 
role in this part of the immune system and they are B cells and T cells. B cells derive from the 
bone marrow and upon activation transform into antibody secreting plasma cells (James & 
Herzenberg, 2007) T cells also originate from the bone marrow but mature in the thymus 
(Romagnani, 1995).  
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T lymphocytes 
Activated dendritic cells are potent stimulators of naive T cells, because they express large 
amounts of the costimulatory B7 and CD40 molecules (Delves & Roitt, 2000). T cells can be 
divided into cytotoxic T cells (CD8+ T cells) and T helper cells (CD4+ T cells). The function of the 
CD8 T cells is to kill cells that may have an intracellular infection e.g. virus infection. CD8 T cells 
recognize peptides from foreign proteins expressed on MHC class I molecules. The Th cells can be 
further divided into several subsets based on their cytokine production (as represented in Figure 
2), which can activate or suppress other immune cells or immune functions. Th1 cells that 
produce IFN-γ are very important for clearing intracellular infections (Ruedaad et al., 2010). Th2 
cells that produce IL-4 and IL-13 are more involved in inducing antibody responses crucial for the 
clearing of parasites and extracellular pathogens. Th17 cells that produce IL-17 have been 
suggested to be important for fighting extracellular pathogens. There are also T regulatory cells 
that regulate the immune responses and maintain tolerance by producing TGF-β. One important 
feature of lymphocytes is the constant recirculation through blood, tissues and lymphoid organ. 
This enables them to encounter antigens carried from infected sites by macrophages and DCs 
(Balboa et al., 2010). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Downstream events upon T cell activation. A balance of the Th1, Th2, Th17 and Treg 
cell subsets and their cytokine expression is required in order to contain M.tb. Adapted from 
eBiosciences (http://www.ebioscience.com/ebioscience/litreq.asp). 
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Th1 immune responses 
NK and CD4+ T cells secrete Th1 pro-inflammatory cytokines like IFN-γ and TNF-α upon IL-12, IL-
18, IL-23, IL-27 and IFN release by antigen presenting cells like DCs (as indicated in Figure 2). This 
leads to the activation and proliferation of Th1 type cells. Th1 type cells are the main producers of 
IFN-γ during M.tb infection (Ruedaad et al., 2010). IFN-γ plays the main role in determining 
susceptibility to tuberculosis disease (Jouanguy et al., 1996), disease severity (Demissie et al., 
2006), and treatment outcome (Sahiratmadja et al., 2007). A good IFN-γ response is essential for 
protective immunity against tuberculosis (Britton & Palendira, 2003; and as reviewed by Fletcher, 
2007). A study showed that mice which lack either IFN-γ or the IFN-γR, are highly susceptible to 
mycobacteria. That show the importance of IFN-γ for the control of tuberculosis (Flynn et al., 
1993). In addition to IFN-γ, TNF-α is important in controlling primary tuberculosis infection. TNF-α 
is a cytokine that activates monocytes and it also helps to maintain the integrity of the 
tuberculous granulomas in which M.tb is contained (Stenger, 2005). In addition, as mentioned 
anti-TNF treatment will increase the susceptibility to tuberculosis disease highlighting the 
importance of this cytokine. 
Th2 immune responses 
The immune response of latently infected and tuberculosis diseased persons is predominately of 
Th1 type, however a balance exist between the Th1 and Th2 immune responses. IL-10 is an anti-
inflammatory cytokine and is produced by alternatively activated macrophages (Shaw et al., 
2000), DC, Th2 and subsets of T regulatory cells. IL-10 down regulates IL-12 production, decreases 
IFN-γ production and regulates antigen presentation (Sahiratmadja et al., 2007). In human 
tuberculosis, IL-10 production was higher in anergic patients, both before and after treatment, 
suggesting that M.tb-induced IL-10 production suppresses an effective immune response 
(Boussiotis et al., 2000). IL-10 also activates B cells and Th2 type cells while inhibiting Th1 type 
cytokine production. Activated Th2 type cells secrete IL-4, which also inhibits Th1 cell activity. Th2 
promoting cytokines for example TGF-β, which is produced by M.tb stimulated macrophages 
(Toossi et al., 1995) as well as regulatory T cells, is thought to contribute to inhibition of bacterial 
growth. The Th2 promoting cytokines are required to balance the M.tb induced Th1 type 
response and therefore aid the containment of immunopathology. TGFβ and IL-10 seem to work 
in synergy: TGFβ selectively induces IL-10 production and both cytokines play a role in the 
suppression of IFN-γ production (Othieno et al., 1999). 
Stellenbosch University  http://scholar.sun.ac.za
12 
 
Th17 immune responses 
In mycobacterial infections IL-23 drives activation of Th17 cells and IL-17 production. IL-23 
expression has been shown to increase during M.tb infection. IL-17 seems to play a role in 
granuloma formation (Curtis & Way, 2009). The absence of IL-17 during pulmonary M.tb infection 
only slightly alters the inflammatory response (Khader et al., 2005; Umemura et al., 2007). This 
suggests that IL-17 plays a minor role early in the response, and that the pathogenic role occurs 
as the balance between IFN-γ and IL-17 is altered in favour of IL-17. 
Tuberculosis in South Africa 
Pulmonary tuberculosis leads to 1.3 million deaths worldwide (WHO, 2008). South Africa has 
around 960/100000 population tuberculosis cases per year (Figure 3). South Africa is also the 
country with the highest incidence of new and relapse cases per year (303114 cases; WHO, 2008). 
With the increase of multi-drug resistant cases as well as the association of tuberculosis with HIV 
infection there is a clear problem in South Africa. 
 
 
 
Figure 3: World incidence of tuberculosis (per 100000 population per year) as recorded in 2008. 
 
 
Our study area includes the suburbs of Ravensmead and Uitsig which are in close proximity to 
Tygerberg Hospital with a HIV prevalence of approximately 2% (Kritzinger et al., 2009). Data from 
ongoing epidemiological surveillance in this area indicate that from 1996 to 2008 4930 
tuberculosis disease episodes were recorded. The average annual increase in notification rates 
(1997-2008) was 27.7 per 100000 population per year for new tuberculosis cases. Pediatric 
tuberculosis cases represented 16 % of the total disease burden in this area (Marais et al., 2006). 
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During the same period, 15.1 % of notified tuberculosis cases were also HIV infected. Annual risk 
of M.tb infection in Ravensmead and Uitsig was 4.1 % in 2006 (Kritzinger et al., 2009). This high 
annual risk of infection reflects the high rate of M.tb transmission in this community. Various 
factors including diagnostic delays (Meintjes et al., 2008), poverty and environmental factors 
contribute (Den Boon et al., 2007) to this occurrence.  
 
Study hypothesis and objectives 
Hypothesis 
The evaluation of immune responses of people with differential outcomes of M.tb exposure will 
lead to the discovery of host biomarkers that will increase our understanding of the immune 
response against this organism and aid us in diagnosing and treatment of this disease. In the 
future, it will aid in vaccine development that is important for the control of M.tb.  
Objectives 
To begin with, in Chapter 2 we determined the background and M.tb stimulated peripheral whole 
blood cytokine profiles of children and adults in our study area, Ravensmead and Uitsig. The 
cytokine patterns of tuberculosis progressors were assessed. In Chapter 3, we aimed to establish 
biomarker profiles in peripheral whole blood of children with different M.tb infection and 
exposure phenotypes. In Chapter 4, we investigated the anti-mycobacterial peripheral whole 
blood immune responses in HIV infected and uninfected children. Lastly, in Chapter 5 we 
investigated the role of the innate immune system in the protective mechanism during human 
M.tb disease and aimed to compare cell frequencies in pleural effusions compared to peripheral 
blood. 
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Chapter2 
Cytokines patterns after acute exposure to Mycobacterium 
tuberculosis 
Introduction 
The aim of this chapter was to determine the cytokine profile of individuals in a high tuberculosis 
incidence setting. The cytokine patterns of tuberculosis progressors were also assessed. This was 
done by measuring the cytokine profiles in stimulated whole blood samples of community 
participants. This would aid the discovery of biomarkers for tuberculosis infection and disease 
specific to this community where latent infection is extremely high. Biomarkers will aid in 
tuberculosis diagnosis and early determination of treatment outcome and can be used in the 
future in conjunction with current available tests to add specificity and sensitivity in tuberculosis 
detection in this study area. Previous work has been done on specific disease phenotypes in the 
same community but never before has a study included large number of healthy community 
participants with no known tuberculosis disease. The information gained in this work will serve as 
reference M.tuberculosis specific cytokines levels in this community with high and on-going 
tuberculosis exposure.  
Methods 
Participants 
The investigation was approved by the Ethics Review Committee of the Faculty of Health 
Sciences, University of Stellenbosch, South Africa (95/072). All participants in this study or their 
legal guardians provided written informed consent for participation in the study. The enrolment 
strategy was to target large households with healthy children and young adults. Priority was given 
to the largest households to allow later reconstruction of nuclear families. This family based 
enrolment strategy was performed for a subsequent genetic study focusing on heritability of anti-
mycobacterial immunity. As part of the bigger study 346 healthy participants were recruited from 
the Ravensmead and Uitsig suburbs in Western Cape, South Africa. In this area in 2008, 375 
tuberculosis cases were notified with an estimated notification rate of 1045/100 000 residents 
(DOH, 2008). BCG vaccination at birth is routine in the study area. All participants belong to the 
Cape Coloured ethnic group. There was no requirement for the participants to be household 
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contacts of tuberculosis cases. If TST reactivity was known at time of enrolment, households that 
contained both TST positive and TST negative subjects were prioritized. Participants who had 
confirmed tuberculosis disease 2 years prior to study were excluded. In addition, those who were 
HIV positive, pregnant, or undergoing chemotherapy were also excluded. The Mantoux skin test 
was carried out on all participants using M. tuberculosis PPD (2 T.U., Statens Serum Institut, 
Copenhagen, Denmark) and skin reactivity was read between 48-72 h after the test using a set of 
callipers calibrated to the nearest 0.5 mm. Skin test results were available for 311 of the 
participants. We completed a review of the tuberculosis treatment register in 2010 at both clinics 
were names, addresses and birth dates were matched to the data available in the register, to 
ascertain whether any participants were treated for tuberculosis during or after completion of 
the study.  
Whole blood stimulation 
Heparinised whole blood (10 mL) was taken from participants and transported to the laboratory 
within 2 hours at 37 oC. Blood was diluted 1 in 10 with RPMI (Gibco, Invitrogen, Carlsbad, 
California, USA) and stimulated in quadruplicate with live whole M. bovis bacillus Calmette-Guerin 
(BCG, Danish 1331 strain, Statens Serum Institut, 1.2 x 106 organisms/ml), early secreted antigen-
6 (ESAT-6; Statens Serum Institut, 20 mg/ml). Staphylococcal enterotoxin B (SEB, Sigma Aldrich, 
St. Louis, Missouri, USA, 10 μg/ml) was used as positive control. An unstimulated negative control 
was included. Cultures were incubated at 37 oC with 5 % CO2 for 7 days, before the supernatants 
were harvested.  
Multiplex immunoassay  
Multiplex immunoassay was only performed on the supernatants of whole blood after 7 day 
stimulation. 
The Multiplex assays were done according to manufacturer’s instructions (Lincoplex, cat no. 
HCYTO-60K, Millipore, Billerica, MA, USA). In short, the 96-well filter plate was blocked with assay 
buffer and an appropriate matrix diluent, in this case RPMI with glutamine (Gibco, Invitrogen, 
Carlsbad, California, USA), was added to all the wells. The 18 antibody covered beads were 
sonicated separately and then added together. This was followed by adding the samples and the 
mixed beads in duplicate to the appropriate wells. After 1 hour incubation on a shaker, the fluid 
was removed by a vacuum pump followed by two wash steps with wash buffer. The biotinylated 
detection antibody cocktail was added into each well and left to incubate on a shaker for 30 min 
where after the streptavidin-phycoerythrin was added to each well. After 30 min incubation on a 
shaker, a vacuum pump gently removed the contents. After another two wash steps sheath fluid 
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was added to all the wells and put on a shaker for 5 min to allow the beads to resuspend. The 
beads were analysed immediately on a Bio-plex array reader (Bio-rad, Hercules, CA, USA). A 
standard curve was used in each assay ranging from 3.2 pg/ml to 10 000 pg/ml. Quality controls 
were provided with each kit to measure the reliability and precision of the selected cytokines. All 
18 cytokines measured fell into the manufacturer’s expected range. As additional quality control, 
a 7 day PHA stimulated supernatant from a healthy volunteer was used on all plates in this 
experiment. For all subsequent analysis the average of the duplicate measurements was used. 
Statistical analysis 
All statistical analyses were conducted using Statistica version 9 (StatSoft, Tulsa, OK, USA). The 
nonparametric Wilcoxon matched pairs test was used to determine differences between ESAT-6 
and BCG stimulated and unstimulated. Spearman’s nonparametric correlation coefficient was 
used to measure correlations. P ≤ 0.05 was considered significant.  
Principal component analysis and heat maps 
Principal component analysis (PCA) was performed and heat maps generated using the Omics 
Explorer, Version 2.0 Beta (Qlucore AB, Lund, Sweden). The PCA operation does not make any 
assumptions regarding the data. 
 
PCA is appropriate when you have obtained measures on a number of observed variables, in this 
case cytokines, and wish to develop a smaller number of artificial variables (called principal 
components) that will account for most of the variance in the observed variables. PCA is a 
variable reduction procedure used when you believe there is some redundancy in the measured 
cytokine concentrations. In this case, redundancy means that some of the cytokines are 
correlated with one another. Reduction of number of variables, by combining two or more 
variables into a single factor This transformation is defined in such a way that the first principal 
component has as high a variance as possible (that is, accounts for as much of the variability in 
the data as possible), and each succeeding component in turn has the highest variance possible 
under the constraint that it be orthogonal to the preceding components. The principal 
components may then be used as predictor in subsequent analyses. The q values are the name 
given to the adjusted p-values found using an optimised false discovery rate approach. The 
smaller the q the better. The false discovery rate approach is optimised by using characteristics of 
the p-value distribution to produce a list of q-values. Qlucore has the added advantage of 
generating heat maps from the PCA analysis. Heat map plots are coloured using normalized data. 
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Each variable has been normalized to mean 0 and variance 1. The colour red corresponds to +2 
and green to ‐2. 
Results  
Demographics 
The median age of participants was 13.67 years and the sex distribution was approximately equal, 
with 49.1 % males and 50.9 % females (Table 1). One hundred sixty seven (48.3 %) participants 
had a positive TST. Fifty-eight participants were between the ages of 0 and 7 years, 164 were 
between the ages of 8 and 15 years and 124 were aged between 16 to 40. Tuberculosis register 
reviews revealed that 9 participants had developed active tuberculosis within 3 years after 
recruitment into this study, at which time tuberculosis had been excluded.  
 
Table 1: Demographic and clinical characteristics of study subjects 
 All subjects 
(n=346) 
Preschool 
(n=58) 
School-
going 
(n=164) 
Adults 
(n=124) 
Age groups (years) 0 - 40 0 - 7 8-15 16 - 40  
Median age (years) 13.67 5.88 12.67 19 
Female1 176 (50.9%)  25 (43.1%) 74 (45.1%) 77 (62.1%) 
TST positive1 167 (48.3%) 11 (19.0%) 77 (47.0%) 79 (63.7%) 
TST unknown1 35 (10.1%) 6 (10.3%) 13 (7.9%) 16 (12.9%) 
TB progressors1,2 9 (2.6%) 1 (1.7%) 1 (0.6%) 7 (5.6%) 
1Numbers of subjects, followed by the percentages of subjects relative to 
the total number of subjects in each age group in brackets, are shown; 
2Tuberculosis progressors developed active disease within 3 years after 
study recruitment. TST = tuberculin skin test; TB = tuberculosis. 
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Cytokines concentrations in population 
In the unstimulated samples IL-1Ra (29.9 pg/ml), sCD40L (11.5 pg/ml), IL-4 (11.0 pg/ml), IL-8 (43.3 
pg/ml), MCP-1 (52.5 pg/ml), RANTES (1478.5 pg/ml) and IP-10 (16.0 pg/ml) were found above the 
lower limit of detection for the assay (Table 2). 
The unstimulated concentration of RANTES was by far the highest measured. After ESAT-6 
stimulation only sCD40L (7.4 pg/ml; p = 0.437) did not increase significantly from the 
unstimulated levels. IL-7 (0 pg/ml) was undetectable and IL-12p70 (0.6 pg/ml) was still below 1 
mg/ml even after stimulation. The low concentration measurement made it difficult to include in 
statistical analysis and it was left out with IL-7. After stimulation with ESAT-6 the biggest increases 
in cytokine concentrations was seen for IL-1α (76.2 pg/ml; p < 0.001), IL-12p40 (13.3 pg/ml; p < 
0.001), IL-8 (9581.0 pg/ml; p < 0.001) and MIP-1α (125.2 pg/ml; p < 0.001), ranging from a 132.5 
fold increase to 1252 fold increase from unstimulated levels. After stimulation with BCG the 
biggest increases in cytokine concentrations was seen for IL-1α (115.9 pg/ml; p < 0.001), IFN-γ 
(428.2 pg/ml; p < 0.001), IL-8 (11100.7 pg/ml; p < 0.001), MIP-1α (258.0 pg/ml; p < 0.001) and 
GM-CSF (91.1 pg/ml; p < 0.001) ranging from a 256.4 fold increase to 2580 fold increase from 
unstimulated levels. The BCG stimulation resulted in highest median cytokine concentrations for 
all cytokines, apart from IL-1Ra and IL-12p40 that was higher after ESAT-6 stimulation. 
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Table 2: Median responses for 18 cytokines as measured by multiplex assay 
 ESAT-6 stimulated BCG stimulated Unstimulated 
Cytokine 
 
Median 
(pg/ml) 
Median fold 
difference 
from 
unstimulated 
p-value Median 
(pg/ml) 
Median fold 
difference 
from 
unstimulated 
p-value Median 
(pg/ml) 
IL-1Ra  945.1 31.6 p<0.001 870.1 29.1 p<0.001 29.9 
TNF-α 114.9 87.0 p<0.001 173.0 131.0 p<0.001 1.3 
IL-1α  76.2 174.3 p<0.001 115.9 265.0 p<0.001 0.4 
IFN-γ 23.9 73.4 p<0.001 428.2 1317.5 p<0.001 0.3 
IL-12p40  13.3 132.5 p<0.001 10.2 102.3 p<0.001 0.1 
SCD40L  7.4 0.6 p=0.437 22.9 2.0 p<0.001 11.5 
IL-12p70  0.7 1.2 p=0.003 0.8 1.3 p<0.001 0.6 
IL-17  1.0 9.9 p<0.001 5.9 59.2 p<0.001 0.1 
IL-10 45.1 47.0 p<0.001 47.9 49.9 p<0.001 1.0 
IL-4  12.0 1.1 p=0.024 12.9 1.2 p=0.001 11.0 
IL-13  1.3 12.6 p<0.001 4.2 42.4 p<0.001 0.1 
IL-8  9581.0 221.3 p<0.001 11100.7 256.4 p<0.001 43.3 
MCP-1 3485.3 66.4 p<0.001 3573.8 68.1 p<0.001 52.5 
RANTES 1502.3 1.0 p=0.020 1924.1 1.3 p<0.001 1478.5 
IP-10  134.5 8.4 p<0.001 891.1 55.7 p<0.001 16.0 
MIP-1α  125.2 1252.0 p<0.001 258.0 2580.0 p<0.001 0.1 
GM-CSF  8.2 82.3 p<0.001 91.1 910.8 p<0.001 0.1 
IL-7  0.0 0.0 p=0.126 0.0 0.0 p=0.346 0.0 
Supernatants from unstimulated and stimulated whole blood were tested for 18 cytokines. Median fold 
differences and P values for significance testing by the Wilcoxon test are also presented.
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Cytokines that correlate with age 
A negative correlation was found with IL-4 (r = -0.23 (unstimulated); r = -0.21 (ESAT-6); r = -0.2 
(BCG)) and increasing age, regardless of stimulation (Table 3). Negative correlations were also found 
for the unstimulated concentrations of sCD40L (r = -0.17), IL-1α (r = -0.15), IL-17 (r = -0.13) and IL-
12p40 (r = -0.11). After BCG stimulation, a negative correlation with age was only seen for IL-10 (r = -
0.12). All negative correlations indicate that there is a trend for these cytokines measured to 
decrease with age. After stimulation, a positive correlation was seen with increasing age for MIP-1α 
(r = 0.13), sCD40L (r = 0.18), IL-17(r = 0.20), IL-1Ra (r = 0.21), GM-CSF(r = 0.24), IP-10 (r = 0.27) and 
IFN-γ (r = 0.29). The only unstimulated cytokine to show a positive correlation with age was IL-8 (r = 
0.11).  
Median cytokine concentrations within the age groups (as described in Table 1) were also assessed 
(Table 4). RANTES (1573.4 pg/ml) and IL-10 (57.5 pg/ml) as measured after ESAT-6 stimulation were 
found to be higher in children 0 – 7 years although not significant (Table 4). After BCG stimulation 
RANTES (2130.4 pg/ml), IL-13 (5.6 pg/ml) and IL-12p40 (12.9 pg/ml) showed highest concentrations 
in the age group 8 – 16 years, again not significant. Unstimulated concentrations of RANTES (1703.1 
pg/ml) showed a similar pattern with the highest concentrations in the age group 8 – 16 years. 
Considering that, young children were included in the study (Table 1) the possibility exists that 
recent BCG vaccination can lead to false positive TST results. In addition, since correlations with 
cytokine concentrations were found, although relatively low, it can also have an influence on other 
analyses. In order to assess if age should be corrected for in subsequent analyses, a one-way ANOVA 
test of variance was performed. It was found that a positive TST was associated with children older 
that 16 years and a negative TST with children under 12 years of age (Figure 4) indicating that no age 
adjustments is necessary. Further analysis were performed in children under 16 years looking at 
specific cytokine concentrations and it was found that adjusting for age had no effect on the 
outcome of results (comparative plots shown in appendix 1).  
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Table 3: Spearman correlations of cytokines in relation to age 
Cytokines Spearman r value Spearman p value # cases Observed trend 
IL-4 (Unstim) -0.23 p<0.010 345 decrease with age 
IL-4 (ESAT6) -0.21 p<0.010 346 decrease with age 
IL-4 (BCG) -0.20 p<0.010 346 decrease with age 
SCD40L (Unstim) -0.17 p<0.010 345 decrease with age 
IL-1α (Unstim) -0.15 p<0.010 345 decrease with age 
IL-17 (Unstim) -0.13 p=0.020 345 decrease with age 
IL-10 (BCG) -0.12 p=0.028 346 decrease with age 
IL-12p40 (Unstim) -0.11 p=0.036 345 decrease with age 
IL-8 (Unstim) 0.11 p=0.033 345 increase with age 
MIP-1α(ESAT6) 0.13 p=0.014 346 increase with age 
IL-17 (BCG) 0.13 p=0.014 346 increase with age 
SCD40L (ESAT6) 0.18 p<0.010 346 increase with age 
IL-17 (ESAT6) 0.20 p<0.010 346 increase with age 
GM-CSF (BCG) 0.21 p<0.010 346 increase with age 
IL-1Ra (ESAT6) 0.21 p<0.010 346 increase with age 
IL-1Ra (BCG) 0.22 p<0.010 346 increase with age 
GM-CSF (ESAT6) 0.24 p<0.010 346 increase with age 
IP-10 (ESAT6) 0.27 p<0.010 346 increase with age 
IFN-g (ESAT6) 0.29 p<0.010 346 increase with age 
IP-10 (BCG) 0.29 p<0.010 346 increase with age 
IFN-γ (BCG) 0.30 p<0.010 346 increase with age 
Supernatants from unstimulated and stimulated whole blood were tested for 18 cytokines. 
Stimulation condition is shown in brackets. P values for significance testing are also presented. 
The condition under which cytokine was measured is indicated in brackets after cytokine 
name. 
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Table 4: Median responses for 18 cytokines stratified according to age 
Supernatants from unstimulated and stimulated whole blood were tested for 18 cytokines 
  
 
ESAT-6 stimulated BCG stimulated Unstimulated 
Cytokine Median (pg/ml) Median (pg/ml) Median (pg/ml) 
Age bracket 0-7 8-16 17-40 0-7 8-16 17-40 0-7 8-16 17-40 
RANTES 1573.4 1469.7 1471.8 1517.7 2130.4 1741.1 1312.7 1703.1 1279.8 
IL-1Ra 899.3 855.5 1260.9 828.3 804.1 1054.1 30.1 28.0 35.9 
IL-4  17.2 12.1 10.5 15.4 13.0 10.5 15.2 11.4 9.2 
IL-7  0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
IL-8 8905.6 9424.7 9726.9 10870.8 11147.7 11125.4 41.3 36.0 56.6 
IL-10 57.5 43.5 41.4 55.3 47.9 44.7 1.5 0.9 0.9 
IL-12p70 0.7 0.7 0.8 0.8 0.7 0.8 0.6 0.6 0.6 
IL-13 0.6 1.2 1.9 4.1 5.6 3.6 0.0 0.0 0.0 
IL-17  0.5 0.8 2.4 4.0 5.8 6.5 0.0 0.0 0.0 
IL-1α 64.0 77.2 93.7 97.8 117.4 124.8 2.0 0.6 0.0 
IFN-γ 2.6 19.7 147.5 211.3 366.8 770.8 0.4 0.3 0.3 
GM-CSF  3.4 6.0 32.3 53.1 89.5 120.7 0.0 0.0 0.0 
TNF-α 121.1 109.1 124.7 159.2 170.2 191.2 1.5 1.4 1.2 
MCP-1 3204.5 3546.1 3407.1 3523.4 3600.2 3550.3 87.1 47.6 52.2 
SCD40L  4.7 5.9 15.9 19.4 21.3 25.9 12.8 12.0 10.1 
IL-12p40  13.5 14.7 7.4 1.1 12.9 10.0 0.0 0.0 0.0 
MIP-1α 103.4 92.2 161.9 187.7 258.3 287.0 0.0 0.0 0.0 
IP-10  43.0 125.9 412.7 436.8 619.2 1474.4 19.0 13.6 16.2 
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Figure 4: ANOVA analysis of age and TST results of the whole study group. P values for significance 
testing are also presented. 
 
 
Cytokines that correlate with IFN-γ 
IFN-γ is used in commercial assays as a proxy for tuberculosis infection. To assess which other 
cytokines measured correlate with this Th1 cytokine Spearman correlation was performed. Even 
though most cytokines did correlate with IFN-γ, the highest correlations was seen with IL-13 (r = 
0.79, p < 0.01; r = 0.72, p < 0.01), IL-17 (r = 0.80, p < 0.01; r = 0.68, p < 0.01), GM-CSF (r = 0.92, p < 
0.01; r = 0.89, p < 0.01), sCD40L (r = 0.73, p < 0.01; r = 0.76, p < 0.01), TNF-α (r = 0.5, , p < 0.01; r = 
0.62, p < 0.01) and IP-10 (r = 0.91, p < 0.01; r = 0.75, p < 0.01) after stimulation with ESAT-6 (Figure 5) 
and BCG (Figure 6),respectively. 
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Figure 5: Cytokines that correlate with IFN-γ after ESAT-6 stimulation. Graphs are representative of the cytokines 
that showed strong correlation (r > 0.6) with IFN-γ. P values for significance testing are also presented. 
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Figure 6: Cytokines that correlate with IFN-γ after BCG stimulation. Graphs are representative of the cytokines 
that showed strong correlation (r > 0.6) with IFN-γ. P values for significance testing are also presented. 
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Cytokine differences between latently infected and uninfected participants 
The TST result was used to group participants into clinical phenotypes of latently infected (a positive 
TST) and uninfected participants (a negative TST). Unstimulated values were subtracted from the 
stimulated values and used for PCA (Figure 7). PCA based analysis applying most stringent conditions 
within the data set of the whole group, differentiates TST positive individuals from TST negatives (as 
in panel B) in a highly significant fashion (p = 6 x 10-37, q = 5.27 x 10-36). After ESAT-6 stimulation 
similar results was found as seen in panel D again highly significant (p = 3 x 10-36, q = 2.63 x 10-36), but 
after BCG stimulation no clear difference was seen between the TST positive and negative group 
after applying a cut off (p =9.5 x 10-15, q = 1.93 x 10-14). Heat maps (Figure 8) after PCA showed that 
within the whole group, sCD40L, IFN-γ and IL-13 responses (all after ESAT-6 stimulation) were the 
best markers to distinguish between latently infected and uninfected healthy participants. After 
analysing the ESAT-6 stimulated samples similar results were found (Panel C). However, upon BCG 
stimulation, sCD40L, IFN-γ and GM-CSF showed to best ability to distinguish between latently 
infected and healthy participants. 
Cytokine differences between tuberculosis progressors and healthy 
participants 
In the unstimulated samples significantly higher concentrations of IL-10 was seen in participants who 
progressed to tuberculosis disease within 3 years after study enrolment (n = 9; p = 0.033). This was 
in comparison to healthy participants (n = 338) (including those who were previously treated for 
tuberculosis prior to enrolment into the study (n = 18; p = 0.046) (Figure 3). The demographics for 
tuberculosis progressors are included in Table 1.  
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Figure 7: PCA plots of all the study participants that are TST positive (in green) and TST negative (in blue). 
The whole group as seen before analysis (A) and (B) after PCA (p = 6 x 10-37, q = 5.27 x 10-36). After ESAT-6 
stimulation, the group as seen before analysis (C) and (D) after PCA (p = 3 x 10-36, q = 2.63 x 10-36). After 
BCG stimulation, the group as seen before analysis (E) and (F) after PCA (p =9.5 x 10-15, q = 1.93 x 10-14). 
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Figure 8: Heat map showing cytokine responses after PCA in the whole study group ordered by hierarchical clustering (Spearman correlation with average linkage) creating a condition tree, upper horizontal 
edge of heat map; study grouping are the coloured blocks at the top of each profile. Heat map rows are the cytokines and columns are the participants. Heat map plots are coloured using normalized data. 
Each variable has been normalized to mean 0 and variance 1. The colour red corresponds to +2 and green to ‐2. First panel is representative of the whole study group before PCA analysis (A) applyng the 
same conditions as mentioned for PCA. After analysis of the whole group, ESAT-6 and BCG stimulated samples, 3 cytokines showed differences between the TST positive (in blue) and TST negative (in green) 
groups (B). After analysis of the ESAT-6 stimulated group (C) and the BCG stimulated group (D) more cytokines showed differences between the TST negative and TST positive groups. 
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Figure 9: Unstimulated IL-10 concentration measured in participants with a history of 
tuberculosis before study enrolment (n = 18), those who developed tuberculosis after the 
study (n = 9) and healthy participants (n = 319; infected and uninfected). P values for 
significance testing are also presented.  
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Discussion 
Given the high tuberculosis notification (Verver et al., 2002) and transmission rate in this community 
(Kritzinger et al., 2009) it is expected that we will see high latent infection rates amongst people of 
the study community. Hence, we present cytokine levels that can be seen as reference values for 
this community specific to a high tuberculosis incidence setting. Reference values in such a large 
cohort can be useful in future studies especially for children as they may vary physiologically with 
age and differ from those of adults (Berdat et al., 2003). The measurement of the levels of cytokines 
of immune activation can provide reliable information regarding the disease diagnosis, disease 
stage, prognosis and the evaluation of therapy (Aziz et al., 1998). Reference values therefore can be 
used as a guide to assess immune status during disease and/or infection.  
The Multiplex assay enabled the investigation of 18 cytokines in the same sample. Cytokine 
concentrations were determined in unstimulated, ESAT-6 and BCG stimulated plasma samples. In 
the unstimulated samples, 11 cytokines tested showed low or undetectable concentration. One 
reason could be that these cytokines are not being produced in this 7 day culture or that these 
cytokines are being produced but at levels below the sensitivity of the Multiplex assay. Alternatively, 
IL-Ra, sCD40L, IL-4, IL-8, MCP-1, RANTES and IP-10 are spontaneously produced in the unstimulated 
samples during the 7 day culture suggesting that in vivo activated cells now continue to produce 
cytokines in vitro. In addition, the pro-inflammatory cytokines, IL-1Ra and IL-8 that are present could 
stimulate the further production of the chemo attractant cytokines, MCP-1 and RANTES. The 
possibility exist that the cytokines are produced to regulate the cellular process under unfavourable 
culture conditions. Since BCG is prepared from a strain of the attenuated live Mycobacterium bovis, 
a more robust, and non-specific, immune response is seen against this vaccine. Whereas ESAT-6, 
that is absent from this vaccine strain, is a small protein and specific to M.tb therefore a more 
tuberculosis specific immune response is seen in the cytokines measured (as discussed in Chapter 2). 
Apart from IL-1Ra and IL-12p40 all cytokines were produced at higher median concentrations after 
BCG stimulation than after ESAT-6 stimulation.  
Cytokines that showed correlation with age had relatively low r-values indicating that even though a 
correlation is significant, age is not the only role player in this correlation. The possibility exist that 
other factors, which were not taken into account in the present study, play a role in the correlations 
seen here. Other factors can include for example genetic variations within the group of children. 
Subsequent analysis showed that in this group, which consisted mostly of children, no further 
adjustment for age is needed. A study in a similar community near Cape Town found in young 
children that there were no independent associations between ethnicity, gender, age, over-crowding 
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and TST results (Pan et al., 2010), leaving us confident that no further adjustments for these factors 
are needed. 
Cytokines that showed a negative correlation with age, IL-4, sCD40L, IL-1α, IL-17, IL-10 and IL-12p40, 
were all mainly produced by the adaptive immune cells and it is known that the immune system 
does undergo age related changes and that these mainly occur in the adaptive part of the immune 
system (Weiskopf et al., 2009). As young children predominantly have a Th2 type immune response 
one would also expect Th2 cytokines, like IL-4, to decrease with age. Upon stimulation with either 
ESAT-6 or BCG, cytokines that showed a positive correlation with age are mainly Th1 and pro-
inflammatory cytokines. This is expected since BCG and ESAT-6 is known to elicit mainly a Th1 
directed immune responses (Ellner et al., 2000). Since a positive TST is associated with older age, we 
can conclude that the immune responses of the older children are due to exposure and/or infection 
to tuberculosis and should be a Th1 type immune response. The cytokines showing the highest 
association with age is IFN-γ, mainly produced by Th1 cells, and IP-10 that is induced by IFN-γ and 
TNF-α. This is of great interest as risk of tuberculosis infection is age related but that exposure in 
young children may have been recent, whereas adults may have had recurrent exposure. Taken 
together we found that a balance of pro- and anti-inflammatory as well as Th1 and Th2 cytokines is 
present at all ages. 
Regardless of stimulation conditions, most cytokines tested correlated highly with IFN-γ, the 
cytokines with the highest correlations being IL-13, IL-17, GM-CSF, sCD40L, TNF-α and IP-10. The role 
of Th2 cytokines in the response to microbial antigens has been debated (Rook et al., 2001). It is 
possible that IL-13, which is closely related to IL-4 (as another Th2 cytokine), is produced in response 
to the high levels of IFN-γ. The cytokines that were produced after stimulation, especially those that 
did not show a strong correlation with IFN-γ, were of main interest. These cytokines can possibly be 
unique to the anti-tuberculosis immune response and can be useful biomarkers for infection and 
disease. 
Several cytokines concentrations were significantly higher in the tuberculosis infected group (as 
determined by a positive TST) than the uninfected group (as determined by a negative TST). This 
included two cytokines that did not show a good correlation with IFN-γ and are of main interest. In 
the unstimulated samples, MCP-1 and IL-1Ra were found to be higher in the tuberculosis infected 
group. Higher MCP-1 concentrations in unstimulated samples might be due to a non-mycobacterial 
specific response (as also suggested by Lalor et al., 2010). Since we did not find MCP-1 to show 
significant differences after stimulation in the TST positive group that might just be the case that it is 
non-specific. IL-1Ra, MIP-1α and IL-1α were also higher in the tuberculosis infected group after 
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stimulation. As production of IL-1Ra is seen in unstimulated samples as well as stimulated samples, it 
could mean that this production is not specific to mycobacterial antigens and similar results were 
found by another study (Ruhwald et al., 2009). Little is known about the role of IL-1α in tuberculosis, 
however earlier work has suggested that it plays a role in tuberculosis susceptibility (Bellamy et al., 
1998). In addition, Lalor et al. (2010) found that after BCG vaccination IL-1α was induced in infants in 
the United Kingdom. MIP-1α and other chemokines as found in our investigation have also been 
shown to be important against protection against tuberculosis (Mendez-Samperio et al., 2008) and 
therefore an increase in chemokines can be beneficial to the anti-tuberculosis immune response. IL-
1α and MIP-1α should be investigated further for it diagnostic ability. After ESAT-6 stimulation, 
significantly higher IL-8 and IL-10 concentrations were seen in the tuberculosis infected group in our 
study. PCA found that after ESAT-6 stimulation, sCD40L, IFN-γ and IL-13 concentration were higher in 
the TST positive population compared to the TST negative population. As discussed it was found that 
these cytokines all showed high correlation with IFN-γ and is part of the tuberculosis specific 
immune response. Similar results were found after BCG stimulation with sCD40L, IFN-γ and GM-CSF 
concentrations being higher in the TST positives. The immune determinants of vaccination-induced 
protection against tuberculosis are not fully understood (Mansoor et al.,2009). However, the Th1 
cytokine response, characterised by IFN-γ, TNF-α and IL-2 production, is widely thought to be 
essential (Mansoor et al.,2009) and now we see that more cytokine that correlate with IFN-γ play an 
important role. 
One notable finding of this study is the presence of IL-10 that was produced at significantly higher 
concentrations in tuberculosis progressors than in healthy participants with and without infection, 
who did not progress to disease. The concentrations in the healthy uninfected participants 
corresponded well with those previously treated for tuberculosis disease prior to study recruitment. 
IL-10 is an anti-inflammatory cytokine and primarily produced by monocytes, is known to have 
important effects during immune regulation and inflammation. It is known to down regulate the 
expression of Th1 cytokines and also suppress the antigen presenting capabilities of APCs. A 
significant increase in IL-10 levels has been reported previously in tuberculosis patients (Hirsch et al., 
1999) compared to TST positive people. In addition, Djoba Siawaya et al. (2009) also showed that the 
levels of IL-10 were significantly higher in slow responders early during treatment suggesting that an 
early increased anti-inflammatory response during treatment may lead to the delay of sputum 
culture conversion in patients. Two genetic studies also found that IL-10 plays a role during 
tuberculosis. They concluded that IL-10 had some specific effect on tuberculosis, by determining the 
disease form and severity, and that IL-10 is not necessarily associated with susceptibility to disease 
(Pacheco et al., 2008; Ansari et al., 2009). 
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In a study that investigated serum IL-10 concentrations before and after tuberculosis treatment it 
was found that IL-10 concentrations are significantly elevated before treatment and decrease again 
after completion of treatment (Hari Sai Priya et al., 2009). However, Hirsch et al. (1999) showed that 
in tuberculosis patients on chemotherapy for active disease, IL-10 levels returned to baseline levels 
as soon as 3 months. It is clear from other work that active tuberculosis is associated with elevated 
IL-10 levels, but here we show that even up to 3 years prior to the development of tuberculosis 
disease and initiation of treatment, IL-10 levels were significantly up regulated compared to healthy 
controls. In the present study a very small number of participants progressed to tuberculosis disease 
and comparison to a large group of healthy controls may not be wholly appropriate. It is also 
important to consider that more differences between cytokines could potentially show if the sample 
size was bigger. There are other limitations to this study. No clinical data were available for these 
participants apart from TST results. In addition, no data were collected capturing tuberculosis 
exposure of these participants. Data collected retrospectively were done by using the local 
tuberculosis register whereas follow up data of these participants would have been ideal. 
In summary, we propose that the cytokine concentrations presented here are representative of a 
community with high levels of tuberculosis exposure and infection. We also present age related 
references cytokine values. Our results suggest that the outcome of M.tb infection is dependent on a 
balance of pro- and anti-inflammatory factors. Receiver operating characteristic (ROC) analysis can 
be used to define diagnostic cut offs for positivity of interesting cytokines and this can also be used 
to determine the percentage of responders. Future studies should include the flow cytometric 
analysis of cell types that can be responsible for the IL-10 production under these conditions. In 
addition, transcriptional analysis of the IL-10 gene can also be done and since IL-10 regulates the 
immune profile, future research should be directed towards determining the exact role of IL-10 
during tuberculosis infection as this cytokine is definitely an important mediator in progression of 
tuberculosis disease. 
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Chapter 3 
Cytokine profiles in children with documented Mycobacterium 
tuberculosis exposure and infection 
Introduction 
The aim of this work presented in this chapter was to determine the differences in cytokine profiles 
of children in a high tuberculosis incidence setting with known tuberculosis exposure and infection 
and those who have no known exposure and no infection. In Chapter 2, we identified cytokines that 
were able to distinguish between TST positive and TST negative children and adults. Therefore, we 
decided to investigate the immune response against tuberculosis further. Here we included an 
exposure gradient of tuberculosis and identified children with documented exposure. The QFT was 
included as a measure of infection in addition to the TST. The investigation was done by measuring 
the cytokine profiles in stimulated plasma samples of participants over time. The information gained 
from this study will reveal the dynamics of the immune response against tuberculosis infection and 
exposure in children. Identification of biomarkers will aid in tuberculosis diagnosis and early 
determination of treatment outcome and can be used in the future in vaccine design.  
Methods 
Participants 
Participants in this nested immunological sub study were included from a larger on-going 
prospective cohort study of HIV uninfected children with different degrees of M.tb exposure. 
Participants were recruited and followed up between February 2008 and May 2009. Enrolment was 
postponed if a TST was placed or if the child was immunized in the preceding 6 weeks. All 
participants were investigated for tuberculosis disease through a symptom-based questionnaire, 
mycobacterial culture or sputum (gastric aspirate in children < 5 years of age) and chest radiography. 
Since no gold standard exist for measuring M.tb infection a formula is used to calculate a ‘contact 
score’ for each household member (Shams et al., 2005; Hesseling et al., 2009). This score quantifies 
the extent of M.tb exposure and therefore was used as proxy for infection. Children exposed to 
newly diagnosed adult tuberculosis index cases in the household and children selected from 
“control” adjacent neighbouring households without a known tuberculosis index case, were included 
in this study. All participants were followed serially at 3 months and again at 6 months after 
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recruitment. During this time no significant changes in tuberculosis exposure was seen. In this high 
tuberculosis incidence setting of Ravensmead and Uitsig the notification rate of tuberculosis in 
children was 407/100000 in 2004 (Marais et al., 2006). In Khayelitsha alone, it is estimated that the 
tuberculosis incidence rate was 1500/100000 in 2009, amongst the highest in the world (DOH, 
2009). BCG vaccination at birth is routine in the study area. The Mantoux skin test was carried out on 
all participants using M. tuberculosis PPD (2 T.U., Statens Serum Institut, Copenhagen, Denmark) and 
induration (mm) was read between 48-72 h after the test using the ball-point pen and ruler method 
(Jordan et al., 1987; Bouros et al., 1989). QFT was completed at baseline, month 3 and month 6; TST 
at baseline and month 3. A positive TST was defined as an induration of ≥ 10 mm as per National 
Tuberculosis Control Management Guidelines (DOH, 2009). 
The investigation was approved by the Ethics Review Committee of the Faculty of Health Sciences, 
University of Stellenbosch, South Africa (N05/07/129). All participants in this study or their legal 
guardians provided written informed consent for participation in the study.   
Eligibility 
Study groups were chosen based on two criteria, 1) M.tb contact score (Hesseling et al., 2009; Table 
5), and 2) M.tb infection status as measured by the TST and QFT tests. When the M.tb contact score 
was ≥ 4 (determined by variables described in Table 5) the participant was classified as ‘Tuberculosis 
Exposed’, < 4 the participant were ‘Tuberculosis Unexposed’. When the TST and QFT were both 
positive the participant was classified as ‘Infected’ and when both tests were negative ‘Uninfected’. 
Participants were included in this study when their infection and exposure status remained 
unchanged for the next 6 months. In each the exposed infected and exposed uninfected groups 17 
participants were included and in the unexposed uninfected control group only 11 participants were 
included. 
QuantiFeron Gold In tube (QFT) 
The QFT test was performed on all study subjects and interpreted for latent tuberculosis infection 
according to the manufacturer’s instructions (Cellestis Limited, Carnegie, Victoria, Australia). In 
short, 1mL of whole blood was stimulated in each a nil, mitogen (PHA coated) or antigen tube 
(coated with a peptide cocktail of ESAT-6, CFP-10 and TB7.7). Tubes were incubated overnight at 37 
°C with 5 % CO2 and plasma was assayed for IFN-γ production by ELISA. For the ELISA plate was 
coated with conjugate and samples, controls and standards were added to the appropriate wells. As 
additional quality control, a 7 day PHA stimulated supernatant from a healthy volunteer was used on 
all plates in this experiment. Plates were incubated at room temperature for 2 hours and then 
washed. Enzyme substrate solution was added to all wells and the plate mix on a micro plate shaker 
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for 5 min. This was followed by incubation at room temperature in the dark for 30 min. Enzyme 
stopping solution was added to each well and mixed again. Plate was read at 450 nm, with a 650 nm 
reference filter. A standard curve was used in each assay ranging from 0.25 IU/mL to 4 IU/mL. QFT 
analysis software (Cellestis) was used to analyse raw data and to calculate results. 
Multiplex immunoassay  
The Multiplex assays were done according to manufacturer’s instructions (Lincoplex, cat no. HCYTO-
60K, Millipore, Billerica, MA, USA). In short, the 96-well filter plate was blocked with assay buffer. 
The 21 antibody covered beads were sonicated separately and then added together. This was 
followed by adding the samples and the mixed beads in duplicate to the appropriate wells. After 1 
hour incubation on a shaker, the fluid was removed by a vacuum pump followed by two wash steps 
with wash buffer. The biotinylated detection antibody cocktail was added into each well and left to 
incubate on a shaker for 30 min where after the streptavidin-phycoerythrin containing the detection 
antibody cocktail was added to each well. After 30 min incubation on a shaker, a vacuum pump 
gently removed the contents. After another two wash steps sheath fluid was added to all the wells 
and put on a shaker for 5 min to allow the beads to resuspend. The beads were analysed 
immediately on a Bio-plex array reader (Bio-rad, Hercules, CA, USA). A standard curve was used in 
each assay ranging from 3.2 pg/ml to 10 000 pg/ml. Quality controls were provided with each kit to 
measure the reliability and precision of the selected cytokines. All 21 cytokines measured fell into 
the manufacturer’s expected range. As additional quality control, a 7 day PHA stimulated 
supernatant from a healthy volunteer was used on all plates in this experiment. For all subsequent 
analysis, the average of the duplicate measurements was used. 
Statistical analysis 
All statistical analyses were conducted using Statistica version 9 (StatSoft, Tulsa, OK, USA) and 
Graphpad Prism (version 5 for Windows, GraphPad Software, San Diego California, USA). All results 
were transformed using the logarithm base-10 to reduce variance in distributions. The 
nonparametric Wilcoxon matched pairs test was used to determine differences between stimulated 
and unstimulated. For all further analysis unstimulated (nil) values have been subtracted from the 
antigen stimulated values. Groups (exposed infected compared to exposed uninfected and exposed 
uninfected compared to unexposed uninfected) were analysed by nonparametric ANOVA with the 
Dunn’s post-test. The degree of association between cytokines was calculated using Spearman’s 
nonparametric correlation coefficient. P ≤ 0.05 was considered significant. 
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Principal component analysis and heat maps 
Principal component analysis (PCA) was performed and heat maps generated using the Omics 
Explorer, Version 2.0 Beta (Qlucore AB, Lund, Sweden). The PCA operation does not make any 
assumptions regarding the data. 
PCA is appropriate when you have obtained measures on a number of observed variables, in this 
case cytokines, and wish to develop a smaller number of artificial variables (called principal 
components) that will account for most of the variance in the observed variables. PCA is a variable 
reduction procedure used when you believe that, there is some redundancy in the measured 
cytokine concentrations. In this case, redundancy means that some of the cytokines are correlated 
with one another. This transformation is defined in such a way that the first principal component has 
as high a variance as possible (that is, accounts for as much of the variability in the data as possible), 
and each succeeding component in turn has the highest variance possible under the constraint that 
it be orthogonal to the preceding components. The principal components may then be used as 
predictor in subsequent analyses. Qlucore has the added advantage of generating heat maps from 
the PCA analysis. Heat map plots are coloured using normalized data. Each variable has been 
normalized to mean 0 and variance 1. The colour red corresponds to +2 and green to ‐2. 
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Table 5: Formula for calculating M.tb contact score  
 
 
 
 
 
 
 
Table reproduced from Hesseling et al. (2009) with permission. TB = tuberculosis. 
 
  
Variable Weight assigned 
Relationship to TB index  
  No known TB contact 0 
  Non-household TB contact 1 
  Relative/other contact in household with TB 2 
  Secondary caregiver (care provider during day) in household with TB 3 
  Primary caregiver in household with TB 4 
Infectivity of TB index case  
  No known TB contact 0 
  Sputum acid-fast negative 2 
  Sputum acid-fast positive 4 
Type of exposure to TB index case  
  No known TB exposure 0 
  Lives and sleeps in different house 1 
  Lives and sleeps in same house 2 
  Sleeps in same room 3 
Duration (total hours) average contact per day with TB index case  
  No known TB contact 0 
  0-3 hours 1 
  4-7 hours 2 
  8-11 hours 3 
  ≥ 12 hours 4 
Total contact score (maximum = 15)  
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Results 
Demographics 
Forty five participants were included in the study. The median age ranged from 3.4 to 7.5 years with 
58.8 % male and 41.2 % female (Table 6). Exposed infected group consisted of QFT and TST positive 
and positive contact score individuals. Exposed uninfected group consisted of QFT and TST negative 
and contact score positive individuals. The unexposed uninfected group consisted of individuals that 
are QFT and TST negative as well as contact score negative. TST results indicated that TST 
indurations increased within 3 month in the positive group (Figure 10). 
Table 6: Demographic and clinical characteristics of study subjects 
 Exposed 
Infected 
(n=17) 
Exposed 
Uninfected 
(n=17) 
Unexposed 
Uninfected 
(n=11) 
Median age (years)1 6.8 (1.4-14.5) 3.4 (1-10.1) 7.5 (0.6-11.4) 
Median TST induration at baseline (mm)1 17 (11-23) 0 (0) 0 (0) 
Median TST induration at 3 months (mm)1 20 (14-28.7) 0 (0) 0 (0) 
Median contact score2 7 (4-15) 8 (4-13) 0 (0-3) 
Female3 7 (41.2%) 9 (52.9%) 11 (100.0%) 
1Median is shown with range in brackets; 2High contact score defined as ≥4 and a low 
score defined by <4; 3Numbers of subjects, followed by the percentages of subjects 
relative to the total number of subjects in each age group in brackets, are shown. TST = 
tuberculin skin test. 
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Figure 10: Distribution of TST readings (in mm) between measurement at baseline and at 3 
months. 
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Cytokine concentrations in population 
Considering that, only young children were included in the study (Table 6) we do not expect to see 
any age related variance in the data and this was confirmed by doing a one-way ANOVA test of 
variance. Further analysis were performed in children under 16 years looking at specific cytokine 
concentrations and it was found that adjusting for age had no effect on the outcome of results 
(comparative plots shown in appendix 1). Higher unstimulated values were found compared to the 
work presented in Chapter 2. A number of factors could contribute to the higher values: firstly, it 
could be due to changes in the optics of the luminex machine over the years; secondly a number of 
operators were involved in running these tests; and thirdly it could be contributed to the differences 
study populations. Careful analysis of the reader data did show that high readings were found for all 
subjects and cannot be contributed to individual samples. 
In the unstimulated samples, all cytokines were found above the lower limit of detection for the 
assay (Table 7 and Table 8). The unstimulated concentration of IL-8 was the highest measured at 
10020.4 pg/ml (exposed infected), 17234.5 pg/ml (exposed uninfected), 9027.0 pg/ml (unexposed 
uninfected) at baseline (Table 7). Regardless of the group IL-1α (exposed infected, p = 0.0004; 
exposed uninfected, p = 0.0016; unexposed uninfected, p = 0.0076) and IP-10 (exposed infected, p = 
0.0003; exposed uninfected, p = 0.0056; unexposed uninfected, p = 0.0058) was significantly 
increased after stimulation with the mycobacterial antigens. MCP-1 (exposed infected, p = 0.0003; 
exposed uninfected, p = 0.0148; unexposed uninfected, p = 0.0058) was decreased after stimulation 
in all three groups. In the unexposed uninfected group IL-8 (p = 0.0409), IL-10 (p = 0.0208), G-CSF (p 
= 0.0128) and TNF-α (p = 0.0329) were all significantly decreased upon stimulation.  
In the exposed uninfected group IL-1β (p = 0.0065) was significantly increased upon stimulation. In 
the exposed infected group IL-8 (p = 0.0395), IL-10 (p = 0.0231) and G-CSF (p = 0.0148) were 
decreased upon stimulation. IL-2 (p = 0.0003), IL-5 (p = 0.0277), IL-13 (p = 0.0049) and IFN-γ (p = 
0.0031) were only increased in the exposed infected group. 
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Table 7: Median responses in 21 cytokines as measured at recruitment in all participants with and without tuberculosis exposure and infection 
 Exposed Infected Exposed Uninfected Unexposed Uninfected 
 M.tb  antigen stimulated Unstimulated M.tb  antigen stimulated Unstimulated M.tb  antigen stimulated Unstimulated 
Cytokine Median 
(pg/ml) 
Median fold 
difference 
from 
unstimulated 
p-value Median 
(pg/ml) 
Median 
(pg/ml) 
Median fold 
difference 
from 
unstimulated 
p-value Median 
(pg/ml) 
Median 
(pg/ml) 
Median fold 
difference 
from 
unstimulated 
p-value Median 
(pg/ml) 
IL-1β  148.5 1.4 p=0.4074 106.7 178.8 2.3 p=0.0065 77.7 71.0 0.8 p=0.3281 87.5 
IL-2  538.8 49.4 p=0.0003 10.9 11.9 1.0 p=0.5695 12.3 14.8 1.2 p=0.1823 12.6 
IL-4  150.9 1.1 p=0.4631 132.6 202.2 1.1 p=0.6874 176.5 620.3 1.3 p=0.9292 476.7 
IL-5  6.3 1.4 p=0.0277 4.6 2.9 1.1 p=0.7960 2.6 8.2 1.6 p=0.9292 5.2 
IL-6  1434.2 0.8 p=0.2274 1695.2 1057.9 1.4 p=0.3812 763.3 1309.1 0.5 p=0.0619 2395.6 
IL-7  67.0 1.0 p=0.0684 70.0 79.7 1.1 p=0.8684 75.8 75.6 0.8 p=0.0619 90.6 
IL-8  4965.0 0.5 p=0.0395 10020.4 17608.8 1.0 p=0.7226 17234.5 4379.5 0.5 p=0.0409 9027.0 
IL-10  48.0 0.5 p=0.0231 96.3 24.3 0.7 p=0.8068 33.7 50.5 0.4 p=0.0208 122.6 
IL-12p70  18.5 0.9 p=0.5540 20.8 22.4 1.0 p=0.3560 23.2 27.5 0.9 p=0.7221 30.4 
IL-13  55.8 2.6 p=0.0049 21.9 16.2 1.3 p=0.8684 12.7 14.4 1.3 p=0.7213 10.7 
IL-15  23.0 1.2 p=0.1239 18.5 28.1 1.0 p=0.4074 28.8 23.3 1.1 p=0.4769 21.5 
IL-17  4.4 1.2 p=0.4631 3.8 0.0 1.0 p=0.6002 0.0 4.8 1.5 p=0.8785 3.1 
IL-1α  2263.9 3.3 p=0.0004 676.9 670.8 1.4 p=0.0016 487.8 1698.2 1.7 p=0.0076 1002.3 
IFN-γ  339.4 9.6 p=0.0031 35.3 54.5 1.1 p=0.5862 48.4 45.8 1.1 p=0.5940 43.1 
G-CSF 316.2 0.7 p=0.0148 456.0 721.5 1.1 p=0.1626 681.6 273.2 0.5 p=0.0128 497.4 
GM-CSF  162.6 1.0 p=0.7226 162.9 102.3 1.1 p=0.7226 94.8 168.0 0.9 p=0.0912 185.0 
TNF-α  129.1 1.4 p=0.7946 94.9 113.8 0.9 p=0.4074 130.5 54.4 0.4 p=0.0329 133.4 
Eotaxin  212.6 1.2 p=0.3088 179.1 187.2 1.0 p=0.0929 196.6 221.2 0.9 p=0.1823 242.1 
MCP-1  1371.6 0.3 p=0.0003 5434.7 3274.9 0.8 p=0.0148 4363.8 1208.7 0.3 p=0.0058 3897.6 
MIP-1α  2166.9 1.1 p=0.4631 1913.7 2470.8 1.1 p=0.7946 2173.4 1457.9 0.6 p=0.0505 2244.2 
IP-10  29989.8 19.8 p=0.0003 1513.4 1517.1 1.4 p=0.0056 1052.4 3869.7 4.7 p=0.0058 824.0 
Supernatants from unstimulated and stimulated whole blood were tested for 21 cytokines. Median fold differences and P values for significance testing by the Wilcoxon test 
are also presented. Values in red are representative of significant decrease from unstimulated median. M.tb = Mycobacterium tuberculosis.
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Table 8: Median responses in 21 cytokines as measured at month 6 in all participants with tuberculosis exposure and with or without infection 
 Exposed Infected Exposed Uninfected 
 M.tb  antigen stimulated Unstimulated M.tb  antigen stimulated Unstimulated 
Cytokine Median 
(pg/ml) 
Median fold 
difference 
from 
unstimulated 
p-value Median 
(pg/ml) 
Median 
(pg/ml) 
Median fold 
difference 
from 
unstimulated 
p-value Median 
(pg/ml) 
IL-1β  156.5 1.2 p=0.0395 128.2 78.1 1.0 p=0.8313 78.5 
IL-2  520.3 71.1 p=0.0003 7.3 8.2 1.1 p=0.6417 7.4 
IL-4  112.8 1.3 p=0.0386 88.5 107.1 0.8 p=0.5862 129.1 
IL-5  7.9 3.7 p=0.0065 2.1 0.7 0.9 p=0.7580 0.8 
IL-6  1881.3 0.8 p=0.5228 2220.5 1899.5 0.8 p=0.0929 2510.7 
IL-7  70.6 0.9 p=0.6529 78.3 67.6 1.0 p=0.3560 67.3 
IL-8  8899.6 1.0 p=0.4348 8561.3 8463.8 0.9 p=0.2274 9392.8 
IL-10  44.6 0.7 p=0.3318 68.4 75.9 0.7 p=0.1128 113.0 
IL-12p70  13.2 1.2 p=0.4348 11.0 14.2 0.9 p=0.4380 15.8 
IL-13  124.8 7.6 p=0.0036 16.5 7.6 1.0 p=0.1914 7.9 
IL-15  14.2 1.6 p=0.0129 9.1 8.2 1.1 p=0.9433 7.5 
IL-17  3.5 1.1 p=0.1477 3.3 1.7 0.7 p=0.9375 2.3 
IL-1α  2686.1 2.3 p=0.0003 1191.1 1255.5 1.7 p=0.0005 760.6 
IFN-γ  344.4 15.6 p=0.0003 22.1 14.8 1.0 p=0.4925 15.6 
G-CSF 331.1 1.0 p=0.6192 317.4 344.4 0.8 p=0.0099 452.4 
GM-CSF  250.7 1.0 p=0.0495 252.5 228.3 1.0 p=0.5228 230.9 
TNF-α  182.8 1.9 p=0.0217 95.9 73.5 0.6 p=0.0049 125.7 
Eotaxin  169.8 1.0 p=0.0086 175.8 182.6 0.9 p=0.6529 195.0 
MCP-1  6779.1 0.8 p=0.4631 7980.9 3255.9 0.4 p=0.0031 8032.3 
MIP-1α  3558.0 1.3 p=0.0313 2815.2 3171.5 1.0 p=0.4631 3032.6 
IP-10  26445.9 7.5 p=0.0003 3542.7 1996.3 2.2 p=0.0004 891.5 
Supernatants from unstimulated and stimulated whole blood were tested for 21 cytokines. Median fold differences and P 
values for significance testing by the Wilcoxon test are also presented. Values in red are representative of significant 
decrease from unstimulated median. M.tb = Mycobacterium tuberculosis.
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At month 6 (Table 8) IL-1α (exposed infected, p = 0.0003; exposed uninfected, p = 0.0005) and IP-10 
(exposed infected, p = 0.0003; exposed uninfected, p = 0.0004) was increased significantly upon 
stimulation. In the exposed infected group IL-1β (p = 0.0395), IL-2 (p = 0.0003), IL-4 (p = 0.0386), IL-5 
(p = 0.0065), IL-13 (p = 0.0036), IL-15 (p = 0.0129), IFN-γ (p = 0.0003), TNF-α (p = 0.0217) and MIP-1 
(p = 0.0313) was increased upon stimulation. Whereas GM-CSF (p = 0.0495) and eotaxin (p = 0.0086) 
were decreased upon stimulation. In the exposed uninfected group G-CSF (p = 0.0099), TNF-α (p = 
0.0049) and MCP-1 (p = 0.0031) were all decreased upon stimulation. 
Cytokines that correlate with IFN-γ 
IFN-γ is used in commercial assays as a proxy for tuberculosis infection. To assess which other 
cytokines measured correlate with this Th1 cytokine Spearman correlation was performed. The 
highest correlations was seen with IL-2 (r = 0.90, p < 0.001), IP-10 (r = 0.76, p < 0.001) and IL-13 (r = 
0.71, p < 0.001) after stimulation (Table 9). IL-2 (r = 0.73, p < 0.001) and IL-15 (r = 0.72, p < 0.001) 
showed strong correlation with IFN-γ in the unstimulated group (Table 9). 
Cytokine differences in the whole group 
PCA applying multiple group comparison, for comparing more than two groups simultaneously, 
differentiates exposed infected from both exposed uninfected and unexposed uninfected in a 
significant way (p = 9.6 × 10-9, q = 2.2592 × 10-8; Figure 14). Heat map of the whole study group 
indicates that there are clear differences between the 3 study groups (Figure 13 A) but only after the 
multiple group comparison IFN-γ and IL-2 (as measured at month 6) and IL-2 (as measured at 
baseline) showed significant differences (Figure 13 B).  
Cytokine differences between exposed infected and exposed uninfected 
participants 
IL-2 (baseline, p ≤ 0.001; month 6, p ≤ 0.001), IL-13 (baseline, p ≤ 0.01; month 6, p ≤ 0.001), IL-1α 
(baseline, p ≤ 0.001; month 6, p ≤ 0.01) and IP-10 (baseline, p ≤ 0.001; month 6, p ≤ 0.001) was 
increased in the exposed infected when compared to the exposed uninfected group. At month 6 IL-5 
(p ≤ 0.001) and TNF-α (p ≤ 0.01) was increased in the exposed infected when compared to the 
exposed uninfected group (Figure 11, B-H). Unstimulated IL-17 showed significant differences (p < 
0.05) between the exposed infected and exposed uninfected groups at baseline (Figure 12). PCA 
applying two group comparison differentiates exposed infected from exposed uninfected 
significantly at baseline by IP-10 and IL-2 (p = 1.6 x 10-4, q = 9.2385 x 10-4, Figure 13 C) and at month 
6 by IL-13 and IL-2 (p = 9.6 x 10-8, q = 3.0172 x 10-9, Figure 15 C).  
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Cytokine differences between exposed uninfected and unexposed 
uninfected participants 
IL-1β (p ≤ 0.05) was increased in the exposed uninfected group when compared to the unexposed 
uninfected group at baseline. At month 6 the IL-1β concentration in the exposed uninfected was 
comparable to the other study groups again (Figure 11 A). Unstimulated IL-17 showed significant 
differences (p < 0.05) between the exposed uninfected and unexposed uninfected groups at baseline 
(Figure 12). PCA applying two group comparison differentiates exposed uninfected from unexposed 
uninfected significantly at baseline by IL-1β and IL-17 (p = 0.0078, q = 0.4457, Figure 13 D) and at 
month 6 by IL-13 and IL-2 again (p = 0.0016, q = 0.0125, Figure 15 D). 
 
 
 
M.tb antigen stimulated Unstimulated 
Cytokines Spearman r value Spearman p-value Cytokines Spearman r value Spearman p-value 
IL-2 r = 0.90 p < 0.01 IL-2 r = 0.73 p < 0.01 
IP-10 r = 0.76 p < 0.01 IL-15 r = 0.72 p < 0.01 
IL-13 r = 0.71 p < 0.01 IL-13 r = 0.50 p < 0.01 
IL-1a r = 0.51 p < 0.01 IL-12p70 r = 0.48 p < 0.01 
TNF-a r = 0.26 p = 0.09 IL-5 r = 0.47 p < 0.01 
IL-5 r = 0.25 p = 0.10 G-CSF r = 0.46 p < 0.01 
IL-1B r = 0.22 p = 0.15 IL-4 r = 0.45 p < 0.01 
IL-17 r = 0.20 p = 0.18 IL-1B r = 0.40 p = 0.01 
IL-15 r = 0.19 p = 0.20 IL-17 r = 0.38 p = 0.01 
GM-CSF r = 0.14 p = 0.37 IL-8 r = 0.38 p = 0.01 
MIP-1a r = 0.12 p = 0.41 IL-7 r = 0.37 p = 0.01 
IL-8 r = 0.09 p = 0.56 IL-10 r = 0.36 p = 0.02 
IL-6 r = 0.08 p = 0.59 IP-10 r = 0.34 p = 0.02 
IL-12p70 r = 0.07 p = 0.65 IL-1a r = 0.34 p = 0.02 
MCP-1 r = 0.05 p = 0.73 MIP-1a r = 0.28 p = 0.06 
G-CSF r = 0.03 p = 0.83 TNF-a r = 0.21 p = 0.18 
IL-7 r = 0.02 p = 0.91 MCP-1 r = 0.18 p = 0.24 
IL-4 r = -0.06 p = 0.71 IL-6 r = 0.10 p = 0.53 
IL-10 r = -0.07 p = 0.66 GM-CSF r = 0.09 p = 0.58 
Eotaxin r = -0.13 p = 0.41 Eotaxin r = -0.06 p = 0.68 
M.tb = Mycobacterium tuberculosis 
 
Table 9: Cytokines that correlate with IFN-γ after M.tb specific antigen stimulation and in the 
unstimulated samples 
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Figure 11: Cytokines that showed significant differences between the study groups. 
Unstimulated values were subtracted from stimulated values. Cytokines that showed 
significant differences between the exposed infected and exposed uninfected groups (B – H) as 
well as the exposed uninfected and unexposed uninfected groups (A). Red bars are baseline 
readings and blue bars month 6 readings. * denote significance of P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 
0.001. 
Figure 12: Unstimulated cytokines that showed a significant difference between the study 
groups. IL-17 showed significant differences between the exposed infected and exposed 
uninfected groups as well as the exposed uninfected and unexposed uninfected groups. Red 
bars are baseline readings and blue bars month 6 readings. * denote significance of P ≤ 0.05. 
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Figure 13: Heat maps at baseline ordered by hierarchical clustering (Spearman correlation with 
average linkage) creating a condition tree, upper horizontal edge of heat map; study grouping 
are the coloured blocks at the top of each profile. Heat map rows are the cytokines and columns 
are the participants. The whole study group (antigen – nil values) as seen before analysis (A) and 
after PCA (B). Red line on (A) indicates a split in the branch in the hierarchical clustering. 
Exposed Infected group compared to the exposed uninfected group after PCA (C). Exposed 
uninfected compared to unexposed uninfected after PCA (D). 
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Figure 14: Principal component analysis (PCA) plots at baseline. The whole group as seen (A) after 
analysis. Exposed Infected group compared to exposed uninfected group after PCA (B). Exposed 
uninfected compared to unexposed uninfected after PCA (C). 
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Figure 15: Heat maps at 6 months ordered by hierarchical clustering (Spearman correlation with 
average linkage) creating a condition tree, upper horizontal edge of heat map; study grouping are 
the coloured blocks at the top of each profile. Heat map rows are the cytokines and columns are the 
participants. The whole group (antigen – nil values) as seen before analysis (A) and after analysis (B). 
Red line on (A) indicates a split in the branch in the hierarchical clustering. Exposed Infected group 
compared to exposed uninfected group after PCA (C). Exposed uninfected compared to unexposed 
uninfected after PCA (D). 
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Figure 16: Principal component analysis at 6 months. The whole group as seen after PCA (A). 
Exposed Infected group compared to exposed uninfected group after PCA (B). Exposed uninfected 
compared to unexposed uninfected after PCA (C). 
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Discussion 
This study was designed with the main aim to investigate the differences in the cytokine profiles of 
children living in households with tuberculosis exposure and those children living in neighbouring 
households with no known tuberculosis exposure. In the tuberculosis exposed group there was 
distinguished between children with known tuberculosis infection and those who were not infected 
at time of recruitment. Infection was measured by a positive result in the commercial QFT assay and 
the TST. 
As discussed in Chapter 1, the QFT assay is used for the detection of latent tuberculosis by 
measuring IFN-γ production after whole blood stimulation with ESAT-6, CFP-10 and TB7.7. Several 
studies have demonstrated the specificity and sensitivity of this assay, and excellent results obtained 
in those with latent tuberculosis (Arend et al., 2001; Mazurek et al., 2005; Pai et al., 2006). IGRAs 
have demonstrated excellent specificity and shown a closer correlation with the exposure gradient 
than the TST (Ewer et al., 2003; Menzies et al., 2007; Arend et al., 2007). Therefore, we can use the 
QFT as a measure of infection in our study. Cytokine concentrations were determined in 
unstimulated and the QFT stimulated plasma samples. In the unstimulated samples, all cytokines 
tested were above the lower limit of detection. After 7 day stimulation some cytokines were not 
detected by the Multiplex assay as found in Chapter 2. In this investigation after overnight 
stimulation, all measured cytokines were detected by the same assay.  
Investigating the effects of whole blood stimulation, we saw that IL-1α (a pro-inflammatory 
cytokine) and IP-10 (an IFN-γ induced chemokine) was significantly increased and MCP-1, another 
chemokine, decreased upon stimulation in all study groups. The same trends were seen for IL-1α, IP-
10 and MCP-1 at month 6. At baseline in the tuberculosis exposed infected group, IL-2 and IFN-γ, 
both Th1 cytokines, and the Th2 cytokine, IL-13 was significantly increased. However, in the same 
group IL-8 (chemokine), IL-10 (anti-inflammatory cytokine) and G-CSF (hematopoietic cytokine) were 
decreased upon stimulation. In the exposed but uninfected group, IL-1β (a pro-inflammatory 
cytokine) was significantly increased upon stimulation. From the results, we see that stimulation 
resulted in an increase of cytokines that are released by adaptive immune cells. When one thinks 
about the immune response against M.tb you would normally expect to see Th1 cytokines. However, 
we see both Th1 and Th2 cytokines are up regulated. This could be to maintain a balance in the 
immune response against M.tb antigens. In the inflammatory cytokines and chemokines we also see 
a balancing effect during stimulation. It has been shown that IL-10 and IL-13 down regulate M.tb 
induced IL-8, IP-10, RANTES and MCP-1 secretion in a cell line (Wright & Friedland, 2003) 
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contributing to the complexity of the immune response and indicating how the response is 
regulated. 
Hierarchical clustering, based on correlations, in the heat maps of the whole group showed all 
cytokines group into two distinct groups the first containing cytokines (containing IP-10, IL-1, IL-2, IL-
4, IL-17, TNF-α amongst others) that are mainly involved in the inflammatory response, cellular 
movement and immune cell trafficking. In the second group (containing IL-1β, IL-10, IL-6, GM-CSF, G-
CSF, MCP-1) in cellular movement, hematological system development and function and immune 
cell trafficking. This indicates that the first group of cytokines, containing those that correlate 
strongly with IFN-γ (IL-2, IL-13, IL-1a and IP-10) are all involved in the inflammatory response against 
M.tb and are up regulated as indicated by the red blocks in Figures 13 and 15.  
Cytokines that showed differences between the tuberculosis infected and uninfected groups were 
IL-5 (at month 6) and IL-13, both Th2 cytokines, IL-2, IL-1α and TNF-α, which are all Th1 cytokines, IP-
10, a chemokine, and IL-17 (only in unstimulated), a Th17 cytokine. These results were confirmed by 
PCA, applying most stringent conditions, that showed that it is possible to distinguish between 
exposed infected and the exposed uninfected by IL-2 and IP-10 at baselines and IL-2 and IL-13 at 6 
months. Coincidentally, these cytokines showed to correlate positively with IFN-γ as expected since 
IFN-γ is widely used as a proxy for tuberculosis infection. IP-10 is induced by IFN-γ and therefore we 
did expect to see differences in IP-10 concentrations (as it showed high correlation with IFN-γ in this 
chapter as well as Chapter 2) between our study groups. This finding is supported by other studies 
for instance work done by Whittaker et al. (2008) and Lighter et al. (2009) who found that IP-10 
could be used as a biomarker in children to determine tuberculosis infection. IL-1α was one of the 
cytokines identified by Chegou et al. (2009) to distinguish latent tuberculosis infection from active 
disease. Chegou’s study, however, did not include children and therefore IL-1α should be further 
investigated for its diagnostic value and should not be disregarding in tuberculosis disease, as our 
study did not include a diseased group.  
The fact that we do not see IFN-γ in this analysis does not mean that IFN-γ is not important to 
distinguish between infected and uninfected children. PCA apply very stringent condition and in this 
case, IL-2 showed bigger difference between the two groups investigated. Distinct IFN-γ and IL-2 
profiles of antigen specific CD4+ T cells have recently been associated with different clinical disease 
states in tuberculosis (Millington et al., 2007). Even more recently, a modified QFT that 
simultaneously measures IL-2 and IFN-γ levels allowed differentiation between latent infection and 
active disease as reported by Glück (2010). From these results, we can conclude that IL-2 would be 
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beneficial to measure in order to distinguish between tuberculosis infection and no infections as well 
as infection and disease.  
IL-1β (higher in exposed group compared to the unexposed) and IL-17 (IL-17 unstimulated value is 
higher in the unexposed group compared to the exposed) are the cytokines that showed differences 
between tuberculosis exposed uninfected and the unexposed uninfected groups. IL-1β is a pro-
inflammatory cytokine and is now believed to be an important molecule that participates in the 
inflammatory response required for the immunological control of infectious diseases like M.tb. IL-1β 
is the main cytokine for the activation of the innate immune system. IL-1β increases have been 
described in those infected or fighting reactivation of M.tb (Garlanda et al., 2007; Kindler et al., 
1989). A genetic study did find that a functional polymorphism in the IL-1β gene influences the 
susceptibility to tuberculosis in a Colombian population (Gomez et al., 2006). This cytokine has also 
been shown to induce IL-10. IL-10, an anti-inflammatory cytokine, is known to have important 
effects during immune regulation and inflammation. It is known to down regulate the expression of 
Th1 cytokines and suppress the antigen presenting capabilities of antigen presenting cells. The fact 
that we found IL-1β to be higher in the exposed group indicates that early immune activation took 
place and that the innate immune systems of these children are sensitized to M.tb. The negative QFT 
and TST are proving that the adaptive immune system is not involved in this immune reaction. This 
highlights the importance of measuring innate cytokines for the detection of tuberculosis infection. 
 
IL-17, the other cytokine that showed differences between tuberculosis exposed uninfected and the 
unexposed uninfected groups, is a pro-inflammatory cytokine, and has been linked to a number of 
chronic inflammatory conditions (Smith et al., 2010). IL-17 is mainly produced by Th17 cells but has 
also been shown that innate γδ T cells also have the ability to produce IL-17 in response to IL-1β 
(Sutton et al., 2009). The Th17 cells development and expansion is driven by the cytokines IL-1, IL-6, 
TGF-β, IL-21 and IL-23 (Sutton et al., 2009). It was thought that Th17 cells may play an indirect role to 
M.tb infection (Kader et al., 2007) but was proven wrong when a distinct subset of memory Th17 
cells with specificity for M.tb was described, that suggested that they have an important 
contribution to the human anti-mycobacterial immune response (Scriba et al., 2008). IL-17 has been 
shown to be higher in TST negative adult participants in a recently study done by Babu et al. (2010). 
In addition, Van de Veerdonk et al. (2010) showed the presence of memory Th17 cells in TST 
negative people, who were not BCG vaccinated, that release IL-17 upon M.tb stimulation. Upon 
exposure, we see a drop in IL-17 concentrations and therefore lower levels is observed than in the 
unexposed (that are known to be TST negative). The reason for the decline in this cytokine in newly 
exposed children should be further investigated as well as the pathways involved. 
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At month 6, after PCA the cytokines that distinguish best between the tuberculosis exposed and 
unexposed is IL-2 and IL-13, with higher concentrations measured in the unexposed group. This 
same cytokines showed differences between the tuberculosis infected and uninfected. Only because 
IFN-γ is below the detection levels of the QFT in the unexposed individuals we cannot say with 
absolute certainty that no tuberculosis infection took place. Previous results did indicate that the 
innate immune system is sensitized to M.tb in these individuals. It is possibly that since the adaptive 
immune system is not involved that the QFT is not enough to detect early infection. Other possible 
reason is that IL-2 could be produced spontaneously and that it is not specific to the stimulation. 
More work needs to performed to confirm this result. Future work should include flow cytometry to 
confirm the origin of the cytokines. The question should also be asked if this is only a phenomenon 
in peripheral blood and what exactly happens at site of disease. 
 
In summary, we showed that IL-1β plays an important role in early tuberculosis exposure (initial 
exposure that sensitize the innate immune system) and higher IL-1β concentration upon M.tb 
antigen stimulation is indicative of recent exposure as IL-1β is one of the first cytokines to be 
secreted upon immune activation. In combination with IL-17, IL-1β can be used in future studies 
where receiver operating characteristic (ROC) analysis can be used to define diagnostic cut offs for 
positivity for these cytokines. These cytokines identified can also be tested in conjunction with 
currently used ones in order to improve on the specificity and sensitivity of tuberculosis detection.  
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Chapter 4 
 
Interferon-γ responses in HIV infected and uninfected children to 
Mycobacterium tuberculosis  
 
Introduction 
In the preceding two chapters, we identified multiple cytokine in children and adults that were able 
to distinguish between tuberculosis infection and exposure. As we are interested in environmental 
influences on the immune response we decided to investigate the immune responses in HIV infected 
and uninfected children. In the other chapters, we stimulated with well known tuberculosis antigens. 
Therefore, we decide to investigate other tuberculosis antigens in HIV. The reason behind this is that 
some work in our lab did show that other antigens showed some promise in determining 
tuberculosis infection in HIV infected adults. The aim of this chapter was to determine the anti-
tuberculosis responses in HIV infected and healthy children who live in a high tuberculosis incidence 
setting. This was done by measuring the IFN-γ responses against known M.tb antigens in stimulated 
whole blood of participants. The information gained in this work will highlight the differences in the 
anti-tuberculosis immune response between HIV infected and healthy children. Knowledge gained 
from this work will help us to improve on current tuberculosis diagnostic tests and aid in vaccine 
development in the future. 
Methods 
Participants 
Sixty children between the ages of 3 months and 15 years were recruited from Tygerberg Hospital in 
the Western Cape, South Africa. Children with known HIV infection were enrolled consecutively from 
the pediatric HIV OPD clinic and HIV unexposed, uninfected children from pediatric OPD clinics were 
enrolled concurrently between June 2008 and January 2009. Enrolment was postponed if a TST was 
placed or if the child was immunized in the preceding 6 weeks. All participants were investigated for 
tuberculosis disease through a symptom-based questionnaire, mycobacterial culture or sputum 
(gastric aspirate in children < 5 years of age) and chest radiography. 
Children were excluded when they weighed less than 5 kg, had documented anaemia, or had been 
on tuberculosis treatment for active disease the last 12 months. Children were not excluded when a 
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TST had been done in the last 3 months or if they were on isoniazid (INH) or anti-retroviral (ARV) 
therapy. In this high tuberculosis incidence setting the notification rate of tuberculosis in children 
was 620/100000 in 2008 (DOH, 2008). The estimated HIV prevalence among South African children 
aged 2- 14 years was 2.5 % in 2008 (DOH, 2008) and the incidence of tuberculosis in HIV infected 
children in the absence of INH preventive therapy was 9.2 % (Zar et al., 2007). A questionnaire was 
completed at recruitment documenting deworming history, household exposure to smoke, if 
children are on INH therapy and additionally in HIV infected children ART and CD4 counts were 
documented. The tuberculin skin test was carried out on all participants using M. tuberculosis PPD (2 
T.U., Statens Serum Institut, Copenhagen, Denmark) and skin reactivity was read between 48-72 h 
after the test using the ball-point pen and ruler method (Jordan et al., 1987; Bouros et al., 1989). 
Skin test results were available for all of the participants. A positive TST in HIV uninfected children 
was defined as an induration of ≥ 10 mm and in HIV infected children as ≥ 5 mm as per National 
Tuberculosis Control Management Guidelines (DOH, 2009).  
The investigation was approved by the Ethics Review Committee of the Faculty of Health Sciences, 
Stellenbosch University, South Africa (N07/10/254). All participants in this study or their legal 
guardians provided written informed consent for participation in the study. 
Whole blood stimulation 
Heparinised whole blood (maximum 6 mL) was taken from participants and transported to the 
laboratory within 2 hours.  Blood was diluted 1 in 5 with RPMI (Gibco, Invitrogen, Carlsbad, 
California, USA) containing 2 mM L-glutamine (Sigma-Aldrich, St. Louis, Missouri, USA) and 
stimulated in triplicate with antigen and mitogen; an unstimulated negative control was included in 
a volume of 100 µL/well, giving a final volume of 200 µL/well. Cultures were incubated at 37 oC with 
5 % CO2 for 7 days, before the supernatants were harvested and stored at – 80 °C. 
Antigens 
Common tuberculosis antigens were selected based on previous work in our laboratory. NTM PPD 
were also included to assess the cross reactivity with M.tb PPD. Whole blood was stimulated with 
ESAT-6 (2 µg/mL), CFP-10 (2 µg/mL), α-crystallin (2 µg/mL), TB10.4 (2 µg/mL), MPT64 (2 µg/mL), BCG 
(10 x 105 cfu/mL), M.tb PPD (2 µg/mL), M. terrae PPD (10 µg/mL), M. scrofalaceum PPD (10 µg/mL) 
and M. avium PPD (10 µg/mL) (all Straten Serum Institut, Copenhagen, Denmark) and P24 (10 
µg/mL) (Fitzgerald Industries International, Acton, MA USA). SEB (0.1 µg/mL) (Sigma-Aldrich) was 
used as mitogen.  
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ELISA  
Stimulated supernatants were thawed to measure IFN-γ concentration (in pg/ml) by ELISA. Plates 
were coated with purified mouse anti-human IFN-γ ELISA capture antibody (1 mg/mL; Becton, 
Dickinson and Company (BD), San Jose, California, USA) and incubated for 5h at 4 °C. Plates were 
washed and blocked with phosphate buffered saline (PBS; Lonza BioScience, Walkersville, Maryland, 
USA) containing 10 % heat inactivated fetal calf serum (FCS; Sigma-Aldrich) for 2 hours at room 
temperature. This was followed by another wash and then samples, controls and standards 
(recombinant human IFN-γ ELISA standard, 25 µg, (BD) were added in duplicate to the appropriate 
wells. As additional quality control, a 7 day PHA stimulated supernatant from a healthy volunteer 
was used on all plates in this experiment. Plates were incubated overnight at 4 °C. Plates were 
washed and biotinylated anti-human IFN-γ ELISA detection antibody (0.5 mg/mL; BD) were added. 
All plates were incubated for 45 min at room temperature followed by a wash step and then avidin 
peroxidase (2.5 g/mL; Sigma-Aldrich) was added to all wells. Plates were incubated at room 
temperature for 30 min followed by a washing step and OPD Fast (Sigma-Aldrich) was added to all 
wells and plates were left to develop in the dark at room temperature. Reaction was stopped with 
the addition of 2 M H2SO4 and the plate was read at 492 nm, subtracting the diluent blank from all 
wells. A standard curve was used in each assay ranging from 31.25 pg/mL to 4000 pg/mL. The lower 
point was chosen to be double the limit of detection of the reader. 
QuantiFeron Gold In tube (QFT) 
The QFT test was performed on all study subjects and interpreted for tuberculosis infection 
according to the manufacturer’s instructions (Cellestis Limited, Carnegie, Victoria, Australia). In 
short, 1mL of whole blood was stimulated in each a nil, mitogen (PHA coated) or antigen tube 
(coated with a peptide cocktail of ESAT-6, CFP-10 and TB7.7). Tubes were incubated overnight at 37 
°C with 5 % CO2 and plasma was assayed for IFN-γ production by ELISA. For the ELISA, the plate was 
coated with conjugate and samples, controls and standards were added to the appropriate wells. As 
additional quality control, a 7 day PHA stimulated supernatant from a healthy volunteer was used on 
all plates in this experiment. Plates were incubated at room temperature for 2 hours and then 
washed. Enzyme substrate solution was added to all wells and the plate mix on a microplate shaker 
for 5 min. This was followed by incubation at room temperature in the dark for 30 min. Enzyme 
stopping solution was added to each well and mixed again. The plate was read at 450 nm, with a 650 
nm reference filter. A standard curve was used in each assay ranging from 0.25 IU/mL to 4 IU/mL. 
QFT analysis software (Cellestis) was used to analyse raw data and to calculate results. 
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Data analysis 
Statistical analyses were performed using Statistica version 9 (StatSoft, Tulsa, OK, USA) and 
Graphpad Prism (version 5 for Windows, GraphPad Software, San Diego California, USA). The whole 
blood IFN-γ assay and QFT IFN-γ results were transformed using the logarithm base-10 to reduce 
variance in distributions. IFN-γ responses to antigens were analysed by nonparametric ANOVA with 
the Bonferroni post-test. To determine the differences between IFN-γ responses between the whole 
blood assay and the QFT, nonparametric Wilcoxon matched pairs test was used with confidence 
interval of 95%. Degree of association was calculated using Spearman’s nonparametric correlation 
coefficient. Multivariate analysis of risk factors for tuberculosis used logistic regression. P ≤ 0.05 was 
considered significant.  
Results 
A total of 60 children were enrolled between April 2008 and December 2008 (Table 10) with equal 
sex distribution within the group. Of these, 32 were HIV infected and 28 HIV uninfected. Median age 
of the study group was 60 months, 58 months for the HIV uninfected and 59 months for the HIV 
infected children. In the study group 46.7 % of participants were TST positive and 66.7 % of 
participants were QuantiFeron In-Tube (QFT) positive. Approximately half of the participants were 
dewormed within the year preceding enrolment into this study. Seventy six point seven percent of 
all children were exposed to smoke in the household. Only seven participants were on INH 
preventative treatment. In the HIV infected group 56.3 % are currently on ART and the median CD4 
count of these participants were 1204 cells/mm3. A positive TST was more common among children 
> 5 years (58.1 %). A negative TST result was most common in the HIV infected group (Figure 17) 
with 20 out of 32 children being negative.  
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Table 10: Demographic and clinical characteristics of participants stratified according to HIV status 
 All (n=60) HIV uninfected 
(n=28) 
HIV infected 
(n=32) 
Female1 30 (50.0%) 15 (53.6%) 15 (46.9%) 
Median age in months
2
 60 (4-165) 58 (6-136) 59 (4-165) 
TST positive1 28 (46.7%) 16 (57.1%) 12 (37.5%) 
QFT positive
1
 20 (66.7%) 13 (46.4%) 7 (21.8%) 
Dewormed
1
 29 (48.3%) 14 (50.0%) 15 (46.9%) 
Exposed to smoke1 46 (76.7%) 26 (62.9%) 20 (62.5%) 
On INH1 7 (11.7%) 5 (17.9%) 2 (6.3%) 
On ART1 na na 18 (56.3%) 
Median CD4 count2 na na 1204 (32-3617) 
 
1Numbers of participants, followed by the percentages of participants relative to the total 
number of participants in each group in brackets, are shown; 2Mean value with range in 
brackets. na: not applicable. 
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Figure 17: Distribution of TST readings (in mm) between the HIV uninfected (n=28) and HIV 
infected (n=32) participants. 
 
 
 
 
 
 
 
Figure 18: Distribution of CD4 counts in the HIV infected participants 
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Considering that, only very young children were included in the study (Table 10) we do not expect to 
see any age related variance in the data and this was confirmed by doing a one-way ANOVA test of 
variance. Further analysis were performed in children under 16 years looking at specific cytokine 
concentrations and it was found that adjusting for age had no effect on the outcome of analysis 
(comparative plots shown in appendix 1).  
When only the HIV positive patients with known CD4 counts (2 were not determined) were 
considered only one child had a CD4 count of below 400 cells/mm3 indicating that the rest of the 
participants are not immune compromised (Figure 18). Higher lymphocyte counts are expected in 
young children and CD4 counts for HIV infected children fell into the range of ‘healthy’ CD4 counts. 
In practice, CD4 counts are not determined for HIV uninfected children and therefore, we are not 
able to correct for CD4 counts in this cohort. 
Analysis between the HIV infected and HIV uninfected participants showed that IFN-γ responses 
following TB10.4 stimulation was significantly higher in the HIV uninfected (Figure 19). To analyse 
the relationship of TST to IFN-γ responses the magnitude of IFN-γ responses between TST positive 
and negative within the HIV infected and uninfected groups (Figure 20) were compared. In both HIV 
infected and uninfected the IFN-γ responses of the TST positive participants were consistently higher 
than those of the TST negatives. The differences were statistically significant within the HIV 
uninfected group after stimulation with ESAT-6 (p < 0.01), CFP-10 (p < 0.01), TB10.4 (p < 0.001), BCG 
(p < 0.05), M.tb PPD (p < 0.001), M. terrae PPD (p < 0.05) and M. avium (p < 0.05). Within the HIV 
infected groups differences were statistically significant after stimulation with TB10.4 (p < 0. 05), 
BCG (p < 0.05) and M.tb PPD (p < 0.001). 
Further analyses were done to investigate the magnitude of the IFN-γ response across age groups 
within the HIV infected and uninfected groups (Figure 21). Within the HIV uninfected group, IFN-γ 
responses against most antigens increased with age but not after stimulation with α-crystallin and 
MTP64, where a decline in responses in children > 5 years was observed. The only statistically 
significant difference was seen at > 5 years between the HIV infected and uninfected after M.tb PPD 
(p < 0.05) stimulation.  
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Figure 19: Comparison of whole blood IFN-γ responses in HIV uninfected (n=15) and HIV infected 
(n=15) participants as measured by ELISA. * denote significance of P ≤ 0. 05. 
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Figure 20: Comparison of whole blood IFN-γ responses in TST negative HIV uninfected (n=12), TST 
negative HIV infected (n=20), TST positive HIV uninfected (n=16) and TST positive HIV infected 
(n=12) participants as measured by ELISA. *** denote significance of P ≤ 0.001, ** denote 
significance of P ≤ 0.01, * significance of P ≤ 0. 05. 
 
Figure 21: Comparison of whole blood IFN-γ responses in participants < 2 years of age and HIV 
uninfected (n=3) and HIV infected (n=9), between 2 and 5 years of age and HIV uninfected (n=9) 
and HIV infected (n=8), and > 5 years of age and HIV uninfected (n=16) and and HIV infected (n=15) 
as measured by ELISA. * denote significance of P ≤ 0. 05. 
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To compare the influence of deworming on the IFN-γ responses the magnitude of IFN-γ responses 
between different time points after routine deworming (Figure 22) was compared. The IFN-γ 
responses were consistently higher after 1 – 3 months following deworming, in the HIV uninfected 
compared to the HIV infected group. IFN-γ responses were statistically higher after stimulation with 
ESAT-6 (p < 0.05), CFP-10 (p < 0.05), TB10.4 (p < 0.01) and M.tb PPD (p < 0.05) in the recently 
dewormed HIV uninfected compared to HIV infected children. In addition, the relationship between 
TST and IFN-γ responses against the HIV antigen P24 (data not shown) in HIV infected children was 
investigated to assess the effect of latent infection (as measured with a positive TST) on the P24 
induced immune response. No statistically significant differences were seen. 
 
Figure 22: Comparison of whole blood IFN-γ responses in participants that were dewormed 1-3 
months ago and are HIV uninfected (n=11) and HIV infected (n=8), those dewormed 6-12 months 
ago and are HIV uninfected (n=4) and HIV infected (n=7), and those not dewormed that are HIV 
uninfected (n=9) and HIV infected (n=11) as measured by ELISA. ** denote significance of P ≤ 0.01, 
* significance of P ≤ 0. 05. 
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The whole blood assay IFN-γ responses as measured after ESAT-6 (r = 0.7301, p < 0.0001) and CFP-10 
(r = 0.6981, p < 0.0001) stimulation showed good correlation with the IFN-γ responses as measured 
by the commercial QFT (Figure 23). In the HIV infected group IFN-γ responses as measured after 
ESAT-6 (r = 0.7067, p= 0.0003) and CFP-10 (r = 0.5416, p = 0.0166) stimulation showed good 
correlation with the IFN-γ responses measured with the commercial QFT (Figure 24). From the 
correlation plots, it is clear that the high correlation is due to mostly low IFN-γ measurements (i.e. 
measured in those with no infection). Some discordant results were also found. The QFT showed a 
significantly lower IFN-γ response compared to the whole blood IFN-γ response after ESAT-6 (p = 
0.0001) and CFP-10 (p = 0.0005) stimulation (Figure 25). In the HIV infected group QFT measured 
IFN-γ responses was again significantly lower than whole blood measured responses after ESAT-6 (p 
= 0.0114) and CFP-10 (p = 0.0143) stimulation (Figure 26). Analysis of IFN-γ responses between 
participants on ART treatment and those who were not on ART did not show any significant 
differences. The same was true for participants on INH treatment and those not on INH treatment 
(data not shown). 
Univariate analysis of the group (Table 11) was performed to investigate the influences of HIV status, 
deworming, exposure to smoke, the QFT result and INH prophylaxis on specific M.tb antigen 
responses. Variables were included for the reasons as listed below. HIV status was included since it is 
known that HIV can have a negative effect on the immune response. Our results have shown the 
effect on deworming on the anti-tuberculosis immune response and therefore we chose to include 
this variable. Passive smoking was shown to be associated with M.tb infection in children living in a 
household with a patient with tuberculosis (Den Boon et al., 2007). Therefore, we wanted to 
investigate this further. The QFT was included in order to assess if the QFT result corresponds well 
with IFN-γ after M.tb antigen stimulation. INH is known to improve the anti-tuberculosis immune 
response (as discussed in Chapter 1) and is therefore included. 
Univariate analysis showed that QFT positivity was significantly associated with IFN-γ responses as 
measured by the whole blood assay after stimulation with M.tb specific antigens (ESAT-6, p < 
0.0001; CFP-10, p < 0.0001; α-crystallin, p = 0.0208; MPT64, p = 0.0006 and TB10.4, p < 0.0001). HIV 
infection was significantly associated with IFN-γ CFP-10 (p = 0.0097) and TB10.4 (p =0.0089) 
responses and exposure to smoking showed significant association with IFN-γ α-crystallin (p = 
0.0245). In HIV infected children QFT positivity (p = 0.0023 and p = 0.0004 respectively) and ART (p = 
0.0136 and p = 0.0306 respectively) showed a positive association with IFN-γ ESAT-6 and CFP-10 
(Table 12). BMI and age showed no association with IFN-γ responses (data not shown) for either the 
whole study group or the HIV infected children. 
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Multiple regression analysis (Table 13) was performed to assess the independent contributions of 
the independent variables, HIV, exposure to smoke, QFT, age, BMI and INH to the prediction of the 
dependent variable, antigen induced IFN-γ responses. The regression slope coefficient (β) indicates 
either a positive correlation exists (as indicated by a positive value) or if a negative correlation exist 
(as indicated by a negative value) between the independent and the dependent variable. 
Independent variables do not need to show a significant contribution to the model in order to be 
included. 
Multiple regression analysis was performed by employing best subsets regression. Best subsets 
regression is a method used to help determine which independent variables should be included in a 
multiple regression model. This method involves examining all of the models created from all 
possible combination of predictor variables. Best subsets regression uses R2 to check for the best 
model. First, all models that have only one predictor variable included is checked, and the two 
models with the highest R2 are selected. Then all models that have only two predictor variables 
included are checked and the two models with the highest R2 are selected, again. This process 
continues until all combinations of predictor variables have been taken into account. 
Multiple regression done for the whole group (Table 13) showed limited association between the 
risk factors associated with M.tb infection and IFN-γ responses after whole blood stimulation. ESAT-
6, CFP-10 and TB10.4 stimulated IFN-γ responses showed association with HIV status, exposure to 
smoke and QFT positivity. However, in addition to the above mentioned factors, after α-crystallin 
stimulation whole blood IFN-γ responses show some association with deworming (p = 0.0327).  
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Figure 23: Correlation between whole blood IFN-γ ESAT-6 responses (left) / CFP-10 responses (right) as 
measured by ELISA and IFN-γ responses as measured by QFT in the study group. 
Figure 24: Correlation between whole blood IFN-γ ESAT-6 responses (left) / CFP-10 responses (right) as 
measured by ELISA and IFN-γ responses as measured by QFT in HIV infected children. 
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Figure 25: Comparison of whole blood IFN-γ responses in the QFT and whole blood ELISA after 
ESAT-6 and CFP-10 stimulation in the whole study group. *** denote significance of P ≤ 0.001. 
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Figure 26: Comparison of whole blood IFN-γ responses in the QFT and whole blood ELISA after 
ESAT-6 and CFP-10 stimulation in only the HIV infected children. * denote significance of P ≤ 0.05. 
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Table 11: Univariate analysis of factors associated with M.tb antigen specific IFN-γ production in children regardless of HIV status 
 ESAT-6 CFP-10 α-Crystallin MPT64 TB10.4 
 Mean 
(log 
pg/ml) 
SE p-value Mean 
(log 
pg/ml) 
SE p-value Mean 
(log 
pg/ml) 
SE p-value Mean 
(log 
pg/ml) 
SE p-value Mean 
(log 
pg/ml) 
SE p-value 
HIV                
  Negative 2.3 0.5 p=0.0599 2.5 0.4 p=0.0097 1.4 0.3 p=0.4368 1.6 0.4 p=0.2289 3.5 0.5 p=0.0089 
  Positive 1.1 0.4  0.9 0.4  1.1 0.3  1.0 0.3  1.7 0.5  
Deworm                
  No 0.9 0.5 p=0.1219 1.0 0.5 p=0.1448 0.8 0.4 p=0.1299 1.0 0.4 p=0.5551 2.0 0.6 p=0.4457 
  Yes 2.0 0.4  2.0 0.4  1.6 0.3  1.3 0.3  2.6 0.5  
Exposure to smoking                
  No 1.3 0.6 p=0.6899 0.9 0.6 p=0.2171 0.3 0.4 p=0.0245 0.8 0.5 p=0.3870 1.5 0.7 p=0.1328 
  Yes 1.6 0.4  1.8 0.3  1.5 0.2  1.3 0.3  2.8 0.4  
QFT                
  Negative 0.4 0.3 p<0.0001 0.3 0.2 p<0.0001 0.9 0.3 p=0.0208 0.7 0.3 p=0.0006 1.4 0.4 p<0.0001 
  Positive 3.9 0.4  4.3 0.3  2.0 0.4  2.4 0.4  4.7 0.5  
INH prophylaxis                
  No INH 1.6 0.3 p=0.6114 1.6 0.3 p=0.9946 1.1 0.2 p=0.2293 1.3 0.3 p=0.6589 2.3 0.4 p=0.0359 
  INH 2.1 0.9  1.6 0.9  2.0 0.6  1.0 0.7  4.6 1.0  
Mean concentration, standard error (SE) and P values for significance testing by ANOVA are presented. M.tb = Mycobacterium tuberculosis; HIV = human 
immunodeficiency virus; QFT = QuantiFeron Gold In tube; INH = isoniazid. 
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Table 12: Univariate analysis of factors associated with M.tb antigen specific IFN-γ production in HIV infected children 
  ESAT-6 CFP-10 α-Crystallin MPT64 TB10.4 
  Mean SE p-value Mean SE p-value Mean SE p-value Mean SE p-value Mean SE p-value 
(log 
pg/ml) 
(log 
pg/ml) 
(log 
pg/ml) 
(log 
pg/ml) 
(log 
pg/ml) 
Deworm                
  No 0.5 0.6 p=0.4431 0.3 0.4 p=0.2424 0.9 0.4 p=0.8690 0.5 0.2 p=0.7629 1.4 0.6 p=0.9814 
  Yes 1.1 0.5  0.9 0.3  1.0 0.4  0.6 0.1  1.4 0.6  
Exposure to smoking                               
  No 1.0 0.6 p=0.7721 0.7 0.4 p=0.9780 0.3 0.4 p=0.0572 0.8 0.3 p=0.8347 1.4 0.6 p=0.8713 
  Yes 0.8 0.4   0.7 0.3   1.3 0.3   0.8 0.3   1.5 0.5   
QFT                
  Negative 0.6 0.4 p=0.0023 0.4 0.3 p=0.0004 1.0 0.3 p=0.5720 0.8 0.3 p=0.3026 1.4 0.4 p=0.0949 
  Positive 3.4 0.8  2.9 0.6  1.4 0.6  1.6 0.6  3.3 1.0  
ART                               
  No ART 2.1 0.5 p=0.0136 1.6 0.4 p=0.0306 1.4 0.4 p=0.3317 1.5 0.4 p=0.0826 2.2 0.6 p=0.2316 
  ART 0.3 0.5   0.3 0.4   0.8 0.4   0.6 0.4   1.2 0.5   
Mean concentration, standard error (SE) and P values for significance testing by ANOVA are presented. M.tb = Mycobacterium tuberculosis; QFT = 
QuantiFeron Gold In tube; ART = antiretroviral therapy. 
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Table 13: Multiple regression analysis of factors associated with M.tb antigen specific IFN-γ production in children 
 ESAT-6 CFP-10 α-Crystallin MPT64 TB10.4 
 β
1
 SE p-value β SE p-value β SE p-value β SE p-value β SE p-value 
Intercept 1.5 0.6 p=0.0219 1.1 0.5 p=0.0406 8.1 2.2 p=0.0010 0.8 0.4 p=0.0518 1.8 0.5 p=0.0013 
HIV -0.8 0.5 p=0.1201 -0.9 0.4 p=0.0301 -0.7 0.5 p=0.1718 -0.2 0.5 p=0.7380 -0.9 0.6 p=0.1475 
Exposure to smoking -0.9 0.6 p=0.1415 -0.3 0.5 p=0.4974 0.9 0.5 p=0.0857 1.7 0.5 p=0.0012 3.0 0.6 p<0.0001 
QFT 3.3 0.5 p<0.0001 3.6 0.4 p<0.0001 -0.5 0.1 p=0.0005 Excluded    1.8 0.9 p=0.0672 
Age in months Excluded3    Excluded    0.9 0.6 p=0.1836 Excluded    Excluded   
Dewormed Excluded    Excluded    1.6 0.7 p=0.0327 Excluded    Excluded   
BMI Excluded    Excluded    Excluded    Excluded    Excluded   
INH Excluded    Excluded    Excluded    Excluded    Excluded   
1 Regression slope coefficient; 2Multivariate regression models excluded the factors. Standard error (SE) and P values for significance testing by ANOVA are 
presented. M.tb = Mycobacterium tuberculosis; HIV = human immunodeficiency virus; QFT = QuantiFeron Gold In tube; BMI = body mass index; INH = 
isoniazid. 
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Discussion 
Tuberculosis disease is one of the most common infections seen in children in areas where HIV is 
prevalent (Swaminathan, 2004) and therefore a tuberculosis vaccine is needed. It is known that cell 
mediated immune responses, specifically those mediated by CD4+ T cells, are important for the 
control of both HIV and tuberculosis. In children with HIV infection, the CD4+ T cells will decrease 
over time and therefore these children are less capable of controlling the replication of M.tb. It is at 
this point when HIV infected children progress rapidly from primary infection to tuberculosis 
disease. Without the recruitment and activation of macrophages by the CD4+ T cell secreted 
cytokines in HIV infected children there is poor granuloma formation, little or absent caseous 
necrosis, poor containment of mycobacteria (Pilheu, 2000). Increased systemic immune activation 
and altered local cytokine micro environment at sites of M.tb infection have been implicated in 
enhanced HIV activity in patients with HIV and tuberculosis. While the in vitro IFN-γ response of 
mononuclear cells to mycobacterial antigens is impaired (Swaminathan, 2004). Similar changes have 
been observed with the other Th1 cytokines like IL-12 and IL-18 (Subramanyam et al., 2004). 
This study investigated the IFN-γ concentrations of antigen stimulated whole blood when incubated 
with M.tb specific antigens in HIV infected and uninfected children in a high tuberculosis incidence 
setting. The information gained in the work highlight the differences in the anti-tuberculosis immune 
response between HIV infected and HIV uninfected children. This will aid to development of vaccines 
for this vulnerable population.  
In both the HIV infected and the uninfected M.tb antigen induced IFN-γ responses in the TST positive 
groups were higher as expected, since TST positivity is used as a proxy for M.tb infection. In the HIV 
infected TST positive group no statistical differences were seen after ESAT-6 and CFP-10 stimulations 
when compared to the HIV infected TST negative group. This indicates that within the HIV positive 
group, one cannot distinguish between infection and no infection after ESAT-6 and CFP-10 
stimulation. However, TB10.4 was found to induce higher IFN-γ responses in the HIV infected TST 
positive children compared to the HIV infected TST negative children, allowing for discrimination 
between infection and no infection. 
Good correlation was found between the IFN-γ measured in the 7 day whole blood assay compared 
to the overnight measured IFN-γ after QFT. However, when specific responses were investigated it is 
clear that higher responses were obtained in the HIV infected after 7 day stimulation indicating that 
HIV infected children are more likely to respond to microbial specific antigens after 7 day 
stimulation. It should be taken into account that very small numbers were included in our study and 
larger studies is needed to confirm this result. Previous studies demonstrated higher sensitivity of a 
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6 day whole blood assay for T cell responses in latent infected individuals, suggesting that prolonged 
in vitro stimulation induced central memory T cells (Leyten et al., 2007; Cehovin et al., 2007). In a 
recent study it was show that M.tb antigens, ESAT6/CFP-10 and TB10.4, induced stronger T cell 
responses in the 16 h assay (comparable to the QFT overnight assay performed here) but 
comparable proportions of IFN-γ producing T cells were detected in the 7 day assay (with 
restimulation during this time) (Schuck et al., 2009). The 7 day assay (with restimulation) detect 
specific T cell responses in latent infected individuals that are missed by the 16 h assay (Shuck et al., 
2009). To summarize, the data suggest that the 7 day assay allows for a more accurate measurement 
of the IFN-γ response, which allows for better identification of latent tuberculosis in HIV infected 
children in our setting. 
Univariate analysis further indicated that HIV infected anti-tuberculosis responses were significantly 
associated with CFP-10 and TB10.4 induced IFN-γ responses. In addition, the HIV infected children 
QFT positivity and ART showed a positive association with IFN-γ responses after ESAT-6 and CFP-10 
stimulation. Since the ESAT-6 and CFP-10 (and TB7.7, but not investigated in this study) antigens are 
used in commercial IGRA (QFT) the possibility exist that it may not be sufficient to detect latent 
infection in the HIV infected children. A study by Mandalakas et al. (2008) found only moderate 
agreement between the TST and QFT in HIV infected children. It is well known that the TST is not 
accurate in the immune compromised. Another study found that ELISPOT assay is more sensitive 
than TST. However, the sensitivity of the ELISPOT assays is not sufficiently high to be used to rule out 
tuberculosis disease (Davies et al., 2009). From this work, it is clear that current tests are not 
sufficient to detect tuberculosis infection or disease in HIV infected children. 
Kampmann et al. (2006) showed that IFN-γ measured anti-mycobacterial responses are lower in 
children under 5 years compared to children between the ages of 5 and 15 years. In this study, we 
found a similar trend in ages 2 to 5 years with anti-mycobacterial responses increasing as children 
get older. In general, T cell immune responses of younger children do demonstrate a decreased 
magnitude than observed in older children and it is known that younger children under 2 years are 
more likely to represent Th2 type immunity (Lewinsohn et al., 2004). One notable finding of this 
study is the increased anti-tuberculosis responses in children after recent deworming (in last 1 – 3 
months). Since helminths is prevalent in most areas with high incidence of tuberculosis (Elias et al., 
2006), controlling helminths, which is known to support a Th2 type immunity, can aid in controlling 
tuberculosis disease. 
Univariate analysis of the whole group showed that QFT positivity was significantly associated with 
IFN-γ responses as measured by the whole blood assay after stimulation with M.tb specific antigens. 
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Exposure to smoking showed significant association with IFN-γ after α-crystallin stimulation. It is now 
known that cigarette smoke affects both the innate and adoptive immune arms (Arnson et al., 
2010). Passive smoking was also found to be associated with M.tb infection in children living in a 
household with a tuberculosis patient. (Den Boon, 2007). In previous studies, cigarette smoke was 
shown to augment the production of numerous pro-inflammatory cytokines such as TNF-α, IL-1, IL-6, 
IL-8 GM-CSF and to decrease the levels of anti-inflammatory cytokines such as IL-10. Cigarette 
smoke has also been shown to activate macrophage and dendritic cell activity (Arnson et al., 2010). 
More studies are needed to confirm this observation, but the possible association is a cause of great 
concern, considering the high prevalence of cigarette smoke and tuberculosis in this area. Multiple 
regression analysis done for the whole study group showed limited association between the risk 
factors associated with M.tb infection and IFN-γ responses after whole blood stimulation. HIV status, 
exposure to smoke and QFT positivity were shown to be predictors of the ESAT-6, CFP-10 and TB10.4 
stimulated IFN-γ responses. 
 
The biggest limitation to our investigation is the study numbers and it is possible that larger numbers 
would have shown more significant differences in all the groups tested. Future studies should 
include multiple cytokine analysis within these same groups by luminex. Flow cytometry would be 
useful to assess the differences between overnight and 7 day whole blood stimulations concerning 
cytokine production within these same groups. 
In summary, our results suggest that detection of tuberculosis infection in HIV infected children 
could be more accurately measured using a 7 day whole blood assay. In addition, ESAT-6 and CFP-10, 
and TB10.4 can be used. Future studies should investigate the use of TB10.4 in detecting 
tuberculosis infection in HIV infected children. Our results showed that deworming HIV uninfected 
children more regularly have been shown to increase their anti-tuberculosis immune responses. 
Knowledge gained from this work will help us to improve on current tuberculosis diagnostic tests, 
especially in the HIV infected children.  
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Chapter 5 
Characterization of quantitative and functional innate immune parameters 
in Mycobacterium tuberculosis diseased adults 
Introduction 
We are interested the innate and adaptive immune system and the changes it undergoes during 
tuberculosis infection and disease. Here we aimed to identify the main innate populations present 
during tuberculosis disease. Limited blood volumes are available from children and it is not easy to 
get samples from the site of disease. For these reasons, we enrolled an adult cohort to answer our 
question. Ex vivo phenotyping of innate cell types in addition to cells of the adaptive immune system 
can provide novel information on the cells present at different stages of tuberculosis disease. 
Comparison of the different disease states will help to determine what is an important anti 
tuberculosis immune response and will therefore aid in future vaccine development. Phenotyping 
was performed on the following cell types: dendritic cells, myeloid derived suppressor cells, natural 
killer cells, invariant natural killer cells, natural killer T cells and T cells, in pulmonary tuberculosis 
patients before and after anti-tuberculosis treatment. Dendritic and myeloid derived suppressor 
cells were investigated in pleural effusions of pulmonary tuberculosis and cancer patients and 
compared to cell numbers in peripheral compartments. 
Methods 
Study participants 
Recruitment took place between July 2009 and June 2010 as a sub study nested within two ongoing 
larger studies. The first was a study on patients with pleural effusions conducted at Tygerberg 
Hospital, which included tuberculosis and cancer patients. These patients were included in this study 
to investigate the difference in innate cell types at site of disease and peripheral compartments. All 
patients with an exudative pleural effusion according to Light’s criteria (Light et al., 1972) were 
included, irrespective of ADA and lymphocyte counts. The main aim of the pleural effusion study is 
to investigate improved bacterial culture techniques on varying volumes of fluid collected with Dr 
Florian von Groote-Bidlingmaier as the principal investigator. As part of the study pleural fluid 
needle aspiration and a closed pleural needle biopsy were performed by experienced 
pulmonologists under ultrasound guidance. Study personnel took a detailed medical history.  
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The participants of the pleural effusions study were stratified into two groups as follows: 
‘Tuberculosis’ group: Comprised of 11 patients with pleural tuberculosis. When examination of 
pleural fluid revealed the presence of acid-fast bacilli by microscopy or M.tb by culture or when 
pleural biopsy specimens yielded a positive culture or granulomatous inflammation with caseous 
necrosis on histology the patient was diagnosed as having tuberculosis pleurisy. All M.tb strains 
identified were drug sensitive. The ages of the tuberculosis patients ranged between 19 and 70 years 
of age, 5 were male and 5 were HIV positive, the remaining six were either negative or the status 
was unknown as data was not collected. 
‘Cancer’ group: Comprised of 10 cancer patients with malignant pleural effusions. Diagnosis was 
based on histological analysis of pleural biopsies or cytological analysis of pleural fluid. Diagnoses 
included non small cell lung cancer, small cell lung cancer, malignant mesothelioma, metastatic 
malignancies (breast cancer, endometrial carcinoma, renal cell carcinoma, gastric carcinoma, 
oesophageal carcinoma) and chronic lymphatic leukemia. The cancer patients were between 47 and 
69 years of age and 5 were male. Since HIV testing was not performed routinely on older cancer 
patients at the study hospital, the HIV status of these patients was unknown. 
 
The second study was community based and included tuberculosis patients and household contacts 
of active tuberculosis cases. Participants were recruited through 4 community clinics in the urban 
suburbs of Ravensmead, Uitsig, Adriaanse and Elsies River in the Western Cape Province, South 
Africa. This case/contact study was carried out as a sub-study of a collaborative longitudinal project 
to discover immune biomarkers of protection against tuberculosis in the context of high HIV 
prevalence. The biomarkers project is part of Grand Challenges in Global Health. An initiative 
launched in 2003 by the Bill & Melinda Gates Foundation and is thus known as the GC6-74 project or 
‘Biomarkers of protective immunity against TB in the context of HIV/AIDS in Africa’ with Prof Stefan 
Kaufmann of the Max-Planck Institute for Infection Biology as project principal investigator and Prof 
Gerhard Walzl as principal investigator at Stellenbosch University. The sub-study required 
tuberculosis patients to be seen additionally at the end of treatment that was not in line with the 
design of the GC6 study and therefore customized case report and treatment outcome forms were 
created for 6 month follow up of tuberculosis patients (Appendix 2).  
 
The participants of the community-based study were stratified into the following three groups:  
‘Before Treatment’ group: Comprised of 20 patients newly diagnosed with active pulmonary 
tuberculosis by chest x-ray and confirmatory bacteriology before the onset of treatment. Ages 
ranged from 18 to 55 years; 7 were male. All were HIV negative. 
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‘End of Treatment’ group: Comprised 12 tuberculosis patients from the same group as described 
above, in the last week of treatment (i.e. following 6 months anti-tuberculosis therapy). Drop out 
occurred to death, missed visits and relocation. Eleven participants in this group were considered 
cured if they had a two negative sputum culture during the last months of treatment. For one 
participant cure was defined according to a chest x-ray alone and the absence of symptoms without 
a sputum result. All were HIV negative. 
‘Household Contact’ group: Comprised of 20 household contacts of active tuberculosis cases. 
Household contact was defined as living in the same house as an adult, sputum smear positive 
tuberculosis case that was diagnosed within the past three months. Ages ranged from 10 to 49 years 
and 10 were male. The Mantoux skin test was completed on the household contacts using M. 
tuberculosis PPD (2 T.U., Statens Serum Institut, Copenhagen, Denmark) and skin test reactivity was 
read between 48-72 hours after the test using a set of callipers calibrated to the nearest 0.5 mm. All 
household contacts were skin test positive (≥ 10 mm induration). All case/contact study participants 
agreed to answer a clinical questionnaire upon enrolment. All were HIV negative. 
In addition to the above-cited groups, a control group were recruited: 
‘Control’ group: Comprised of 17 healthy volunteer laboratory personnel with ages ranging from 23 
to 35 years, without previous history of tuberculosis disease. 5 % of this study group were male. TST 
status of this group was not determined. All were HIV negative. 
 
All patients were treated according to standard treatment protocols that are in use at their health 
care facility. No isoniazid chemoprophylaxis was offered to people with latent tuberculosis infection 
as this is not practiced in HIV negative and healthy adults in this country. Tuberculosis cases were 
treated under the direct observed therapy short course (DOTS) program and received standard 
doses of antibiotics. Treatment consisted of a 2 month intensive phase of rifampicin, isoniazid, 
pyrazinamide and ethambutol, followed by a 4 month continuation phase of rifampicin, isoniazid. 
The treatment of cancer patients depended on their type of malignancy.  
 
This investigation was approved by the Ethics Review Committee of the Faculty of Health Sciences, 
University of Stellenbosch, South Africa (project numbers N10/02/055 and N05/11/187). All 
participants, or their legal guardians, provided written informed consent. 
Sample collection 
Heparinised whole blood (between 10 and 50 mL) was taken from all participants and transported to 
the laboratory within 2 hours. Whole blood was used directly for all subsequent analysis. For 
hospital participants pleural effusions (between 50 and 100 mL) were collected and transported on 
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ice to the laboratory within 2 hours of collection. Effusions were spun down at 400 g for 10 minutes 
and the resulting cell pellets were washed twice before subsequent analysis. 
Immunophenotypic cell staining 
Aliquots of 100 µL whole blood or 100 µL of prepared pleural effusion cells were incubated with 
predetermined concentrations of monoclonal antibodies as described in Table 14. After mixing by 
vortex the tubes were incubated for 20 minutes at room temperature in the dark. One mL of FACS 
Lysing solution (BD Biosciences, San Jose, CA, USA) was added for hemolysis. Mixed by vortex and 
the preparation was incubated for 10 minutes at room temperature in dark. Preparation was mixed 
again and centrifuged for 1400 g for 5 minutes. Supernatant was discarded and resulting cell pellet 
was washed twice with 1 mL of wash buffer (phosphate buffered saline (PBS, Lonza, Walkersville, 
MD, USA) supplemented with 1 % fetal calf serum (FCS, Sigma Aldrich, St. Louis, Missouri, USA). In 
between the washing steps, the preparation was mixed by vortex and centrifuged at 1400 g for 5 
minutes and supernatant discarded. Following the last washing step the resulting cell pellet was 
fixed by the addition of 200 µL 4 % paraformaldehyde (methanol free, Sigma Aldrich) and stored at 4 
°C until analysis. 
Immunophenotypic analysis 
Flow cytometric acquisition was performed on the FACS Aria II or a FACS Canto II (BD Biosciences) 
due to logistical reasons. Instrument calibration was checked daily according to the manufacturer’s 
instructions (BD Biosciences). Compensation settings were adjusted with the use of antibody-
capture beads (CompBeads, BD Biosciences). Further compensation adjustments were made based 
on fluorescence minus one (FMO) controls (Baumgarth & Roederer, 2000). In multicolor 
experiments, it is not possible to set gates based on an entirely unstained or fully isotype stained 
control. In FMO controls one antibody is left out of the panel at a time in order to define the correct 
position for gates. Using a general acquisition gate on the forward scatter and side scatter dot plot at 
least 100000 events were acquired for each cell antibody panel and analysis were performed on 
FlowJo analysis software (version 7.5 and 7.6, Tree Star, Ashland, OR).  
Statistical analysis 
All statistical analyses were performed using GraphPad Prism (version 5 for Windows, GraphPad 
Software, San Diego California, USA). Non-parametric tests were employed. The differences between 
tuberculosis patients before and after treatment was analysed by the Friedman’s test for repeated 
measures, with the Dunn’s post test correction. The differences between tuberculosis patients, 
before and after treatment, their household contacts and controls was analysed by the Kruskal-
Wallis test, with Dunn’s post test for identifying differences between pairs when the P for multiple 
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comparisons was ≤ 0.05. Kruskal-Wallis test with Dunn’s post test correction was used to determine 
differences between tuberculosis and cancer patients when comparing pleural and whole blood cell 
frequencies.  
 
Table 14: Antibody combinations used in this study to identify and characterise frequencies of DCs, 
MDSC and T-cells. A) Combinations used on the FACS Aria and B) combinations used on the FACS 
Canto II in tuberculosis study. C) Combinations used on the FACS Canto II in the pleural effusions 
study 
A DC MDSC T cells 
FITC LIN1 LIN1 CD4 
PE CD83 CD33 6B11 
PE.Cy5  CD80 CD8 
PE.Cy7 CD123  CD3 
APC CD40 CD11b CD56 
APC-AlexaFluor750 HLADR HLADR HLADR 
Pacific Blue CD86  CD16 
Qdot605 CD11c  CD45RA 
 
B DC MDSC T cells 
FITC LIN1 LIN1 CD3 
PE CD83 CD33 6B11 
PE-Cy5 CD11c CD80 CD8 
PE-Cy7 CD123  CD45RA 
APC CD40 CD11b CD56 
APC-eFluor 780 HLADR HLADR HLADR 
Pacific Blue  CD86  CD16 
V500   CD4 
 
C DC  MDSC  
FITC LIN1 LIN1 
PE CD123 CD33 
PE-Cy5  CD80 
PE-Cy7 CD11c  
APC  CD11b 
APC-eFluor 780 HLADR HLADR 
Pacific Blue   CD14 
V500   
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Results  
Gating strategy 
Different gating strategies were employed in order to identify the cell populations of interest as 
described in Table 15. All analyses were started by gating on populations of interest on the SSC/FSC 
plots (Figure 27). For the identification of all lymphocytic populations, the first gate was on the 
lymphocyte populations (Figure 27 A). For the dendritic cells, the gate was set on the lymphocyte 
and monocyte populations (Figure 27 B) and for identification of the myeloid derived suppressor 
cells the gate was set on the lymphocyte, monocyte and granulocyte populations (Figure 27 C). 
From the lymphocyte gate on the SSC/FSC plot CD3 negative and positive cells were defined (Figure 
28 A). This was then used to identify the following lymphocyte populations: T cells, natural killer cells 
(Figure 28 B), natural killer T cells (Figure 28 C) and invariant natural killer cells (Figure 28 D) as 
described in Table 15. 
Non-lymphocytic cell populations were first identified by the lack of LIN1 (lineage marker 1 cocktail 
(BD Biosciences) contains CD3, CD14, CD16, CD19, CD20, and CD56; used as exclusion marker) 
expression. Dendritic cells subpopulations, plasmacytoid and myeloid dendritic cells (Figure 29 B), 
and myeloid derived suppressor cells (Figure 29 A) were identified as described in Table 15. 
 
Table 15: Antibodies used in the identification of different cell populations present during 
tuberculosis disease and cancer 
Cells types identified Monoclonal antibody combinations 
T cells  CD3+  
CD4 T cells CD3+ CD4+ 
CD8 T cells CD3+ CD8+ 
Natural killer cells   CD3- CD16+ CD56+ 
Natural killer T cells CD3+ CD56+ 
Invariant Natural killer T cells  CD3+ 6B11+ 
Plasmacytoid dendritic cells LIN1- HLA-DR+ CD123+ 
Myeloid dendritic cells  LIN1- HLA-DR+ CD11c+ 
Myeloid derived suppressor cells  LIN1-/lo HLADR-/lo CD33+ CD11b+ 
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Figure 27: Gating strategy on the SSC and FCS dot plots for analysis. (A) For analysis of the 
lymphocyte-derived populations a gate was constructed. (B) For dendritic cell analysis a gate 
was constructed around the lymphocytes and monocytes and (C) for myeloid derived 
suppressor cell analysis around lymphocytes, monocytes and granulocytes.  
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Figure 28: Gating strategy for lymphocytic cell populations. From the lymphocyte gate on the SSC/FSC 
plot (A) CD3 negative and positive cells were defined. Natural killer cells were identified by gating on 
the CD3 negative cells that express CD56 and CD16 (B). Natural killer T cells were identified by gating 
on the CD3 positive cells that express CD56 (C). Invariant natural killer T cells were identified by gating 
on CD3 positive cells that express the 6B11 clone of the invariant T cell receptor α chain (D).  
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Figure 29: Gating strategy for non-lymphocytic cell populations. From the lymphocyte, monocyte and 
granulocyte gate on the SSC/FSC plot (A) LIN1 and HLA-DR negative and low staining cells were 
defined. These immature myeloid derived cells were investigated for the positive staining of both 
CD33 and CD11b to identify the myeloid derived suppressor cells. Dendritic cells were identified by 
gating on the lymphocytes and monocytes on the SSC/FSC plot that was used to define (B) LIN1 
negative and HLA-DR positive staining cells. Subpopulations of can be identified as CD123 positive 
staining plasmacytoid dendritic cells and CD11c positive staining myeloid dendritic cells. 
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Differences in T cells and T cell subsets following tuberculosis treatment 
There was a predominance of CD4+ T cell frequencies over CD8+ T cell frequencies in the 3 groups as 
expected (Figure 30 A). Friedman analysis showed no significant differences between the 
frequencies of CD4+ and CD8+ cells in tuberculosis patients before and at end of treatment (data not 
shown). Natural killer T cell frequencies at the end of treatment were comparable to that before the 
start of treatment. However, natural killer T cells were significantly increased at the end of 
tuberculosis treatment compared to that of household infected contacts (Figure 30 B). Friedman 
analysis of the natural killer T cells showed no significant differences before and at end of treatment 
(data not shown). An increase in invariant natural killer cell numbers were seen in tuberculosis 
patients at the end of treatment compared to before treatment but not significantly so (Figure 31 A). 
Phenotypic changes were observed for invariant natural killer T and natural killer T cell as the 
expression of the molecule CD45RA+ increased (Figure 31 B). Compared to the before treatment 
group and household contacts CD45RA+ was significantly higher (p ≤ 0.001) in the end of the 
treatment group. CD45RA is expressed on resting iNKT and NKT cells and upon activation; these cells 
will lose their CD45RA expression. This indicates that following treatment more resting cells are 
circulating than during infection. No differences were seen on invariant natural killer T cells for the 
molecules CD16, CD56 and HLA-DR; the same was observed for the molecules CD16 and HLA-DR on 
the natural killer T cells (Figure 31 B). 
Levels of classic and pre-natural killer cells remained mostly unchanged between the 3 study groups 
(Figure 32 A). However, in tuberculosis patients at the end of treatment there was a significant 
decrease in mature NK cells when compared to before treatment (Friedman test; p ≤ 0.01, Figure 32 
B).  
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Figure 8: Analysis of CD4+ and CD8+ T cells (A) and natural killer T cells (B) frequencies 
before and at the end of treatment in whole blood by flow cytometry. The control group 
consisted of household contacts (HHC) of active tuberculosis cases. *** denote significance 
of P ≤ 0.001. 
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Figure 31: Analysis of invariant natural killer T cells (A) before and after treatment in whole blood by flow 
cytometry. Analysis of surface marker expression on invariant natural killer T cells and natural killer cells, 
before and at end of treatment. The control group consisted of household contacts (HHC) of active 
tuberculosis cases. *** denote significance of P ≤ 0.001. 
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Differences in myeloid derived suppressor and dendritic cells numbers 
following tuberculosis treatment 
Phenotypic analysis of the myeloid derived suppressor cells (LIN1-/lo HLA-DR-/lo CD33+CD11b+) 
showed that significantly reduced numbers were seen in tuberculosis patients at end of treatment 
compared to before treatment (Figure 33 A); confirmed by Friedman analysis (p ≤ 0.05) (Figure 33 B). 
Tuberculosis patients before treatment and HHC had significantly more CD33+CD11b+ cells 
compared to healthy controls (Figure 33 A). Phenotypic changes where oberved in the myeloid 
derived suppressor cells as the expression of the molecule CD80+ (Figure 33 C). The CD80+ cells 
were significantly increased after treatment compared to tuberculosis patients before treatment (p 
≤ 0.001) and household contacts (p ≤ 0.001) and  the healthy controls (p ≤ 0.05). Friedman analysis 
showed that the CD80+ myeloid derived suppressor cells were significantly increased at the end of 
treatment (p ≤ 0.01) (Figure 33 D). 
Phenotypic analysis of total dendritic cells showed no significant differences between the 3 groups 
(Figure 34 A). Nevertheless, in the subsets, plasmacytoid dendritic cells (LIN1-HLA-DR+CD123+) (p ≤ 
0.01 and p ≤ 0.001) and myeloid dendritic cells (LIN1-HLA-DR+CD11c+) (p ≤ 0.01 and p ≤ 0.01), 
significant differences were seen in tuberculosis patients at the end compared to before treatment 
initiation and household contacts. Friedman analysis however showed no differences in dendritic cell 
or subset numbers (Figure 34 B).  
Phenotypic changes were observed in the plasmacytoid subset with the molecule CD86 highly 
expressed (p ≤ 0.001) in tuberculosis patients compared to household contacts. However, expression 
of CD86 is comparable with that of household contacts at end of treatment (Figure 34 C). Friedman 
analysis showed no significant differences for this molecule on plasmacytoid dendritic cells. The 
molecule CD40 showed significant differences between all 3 groups, for both the plasmacytoid and 
myeloid subsets. Friedman analysis showed significant differences in tuberculosis patients before 
and at the end of treatment with higher expression of CD40 at the end of treatment. This was true 
for the plasmacytoid (p ≤ 0.01) and myeloid dendritc cells (p ≤ 0.05) (Figure 34 D). 
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Figure 33: Analysis of myeloid derived suppressor cells (A) and CD80+ subsets (C) before and at end of 
treatment treatment in whole blood by flow cytometry. Household contacts (HHC) of active tuberculosis 
cases and healthy laboratory controls were included (A). Friedman analysis of before and at end of 
treatment (B) of myeloid derived suppressor cells and (D) of the CD80+ subset. *** denote significance of 
P ≤ 0.001, ** significance of P ≤ 0.01, * significance of P ≤ 0.05. 
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Figure 34: Analysis of dendritic cells (A) before and after treatment in whole blood by flow cytometry. 
The control group consisted of household contacts (HHC) of active tuberculosis cases Friedman analysis 
(B) before and at end of treatment of dendritic cells. Analysis of surface marker expression on dendritic 
cells subsets, before and at end of treatment. *** denote significance of P ≤ 0.001, ** significance of 
P ≤ 0.01, * significance of P ≤ 0.05. 
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Differences in myeloid derived suppressor and dendritic cells between 
site of disease and peripheral blood 
Myeloid derived suppressor cells have previously been shown to have a suppressive effect on the 
innate immune system in cancer patients. We found no differences between myeloid derived 
suppressor cell numbers in pleural effusions and whole blood of cancer and tuberculosis patients 
(Figure 35 A). However, higher numbers were observed to be circulating in whole blood 
compared to the site of disease (pleura) even though not significantly so (Figure 35 A). No 
phenotypic changes where oberved in the expression of the molecule CD80+ between all groups 
compared (Figure 35 B). Within the myeloid derived suppressor cell population a CD33hi 
population was identified and further identified to be CD14+. This population therefore can be 
defined as LIN1-/lo HLA-DR-/lo CD33hi CD11b+CD14+ and seems to be a subpopulation within the 
myeloid derived suppressor cells. In cancer patients significant differences were seen for the 
molecule CD14+ (p ≤ 0.05) with higher numbers in pleural effusions than whole blood (Figure 35 
C).  
Dendritic cell numbers were comparable in pleural effusions of cancer and tuberculosis patients 
(Figure 36 A). In the whole blood of tuberculosis patients, significantly higher numbers (p ≤ 0.05) 
were found to be circulating compared to whole blood of cancer patients. As for myeloid derived 
suppressor cells, higher numbers of circulating dendritic cells were seen in blood compared to the 
pleura even though not significantly so (Figure 27 A). The plasmacytoid and myeloid dendritic cell 
subsets showed no differences in percentages in all groups compared (Figure 36 B).  
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Discussion 
Few studies have looked at the differences in innate cell numbers in the peripheral blood and 
other compartments before and at completion of pulmonary tuberculosis treatment. It is 
important to assess parameters before and after treatment in order to understand how 
tuberculosis disease affects the immune system. Investigating these parameters will also allow for 
vaccine development in the future. Here we have evaluated the frequencies of these cells before 
and in the last week of tuberculosis treatment in order to allow for the investigation of 
immunological changes following successful completion of therapy. In addition, differences 
between circulating and site of disease innate cell frequencies were investigated.  
In this study, the T cell frequencies observed are as expected. We observed a predominance of 
CD4+ over CD8+ T cells in whole blood in tuberculosis patients. CD4+ T cells percentages declined 
slightly at the end of treatment, not significantly so, but were still higher than CD8+ T cells. It has 
been shown that during anti-tuberculosis treatment a decrease in sputum bacillary load is 
observed and hence CD4+ T cell numbers might decrease due to weaker stimulation of the 
immune system (Belkaid & Rouse, 2005). Nevertheless, the importance of CD8+ T cells during 
M.tb infection should not be overlooked (Caccamo et al, 2009). Unfortunately, T cell frequencies 
were not assessed at site of disease and should be included in future studies. 
In this study no difference were seen before and after tuberculosis treatment in NKT and iNKT cell 
populations. NKT and iNKT cells are involved in innate immunity and there is increasing evidence 
that suggests that cells are activated and play a protective role against pathogens during 
infection. A study by Sutherland et al. (2009) found that NKT frequencies of active tuberculosis 
cases compared to that of TST positive household contacts. In this study TST negative controls 
were also included and with treatment they found that NKT cell frequencies compared to that 
found in the TST negatives. More studies are investigating the role of these cells during bacterial 
infections. Chiba et al. (2008) found that NKT cell responses are self-terminating during the 
course of infection. Work by Sada-Ovalle et al. (2008) showed that the innate control of bacterial 
replication is dependent on iNKT cells. In addition, iNKT cells, even in limited numbers, are 
sufficient to restrict M.tb replication in vivo by rapidly producing large amounts of IFN-γ when 
activated. Since we saw, no differences in NKT and iNKT frequencies during treatment we can 
only concluded that they are present during active tuberculosis and still present at the end of 
treatment. 
Most of the circulating NK cells were found to be mature NK cells during tuberculosis treatment 
and this is similar to what was found by Barcelos et al. (2006). We also saw significant decreased 
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NK frequencies at the end of treatment. It is known that NK cells are critical in the innate immune 
system and sustain the early innate immune responses until adaptive immune responses can be 
mounted. 
NK cells can be classified as classic NK, pre-NK, and mature NK cells. The role of NK cells during 
M.tb disease and infection is not clear, but it has been suggested that recruitment of pre-NK cells 
to the site of disease could be the linkage between the innate and adaptive immune systems (Sun 
& Lanier, 2009). Our results confirm the presence of NK cells during early tuberculosis disease and 
a decline in mature NK numbers at end of treatment.  
Myeloid derived suppressor cells comprise of immature DCs, immature macrophages and 
granulocytes. Recent studies published have shown that alteration of cytokines during infections 
cause a progressive accumulation of myeloid cells in the spleen, lymph nodes and bone marrow. 
Mice primed with M.tb displayed an expansion of this population (Zhu et al., 2007). Here we 
showed that MDSC were significantly decreased after treatment in tuberculosis patients and that 
healthy controls have far lower numbers compared to tuberculosis patients and their household 
contacts. Further analysis showed that the MDSC frequencies were comparable to that of cancer 
patients both in whole blood as well at the site of disease. Within the myeloid derived suppressor 
cell population a CD33hi population was identified and defined as LIN1-/lo HLA-DR-/lo CD33hi 
CD11b+CD14+. Further identification and analysis is need. It would also be interesting to 
determine the function of the different MDSC populations. 
Comparable to other studies, higher frequencies of MDSCs were found to be circulating than at 
the site of disease, even though not significantly so, implying that some of these immature cells 
mature at the site of disease, possibly due to the cytokine micro environment. Study groups are 
now focusing on how these cells suppress the immune system, especially in cancer. Work by 
Nagaraj et al. (2010) shed some light on the suppressive mechanism of these cells. They found 
when incubating peptide loaded MDSCs with antigen specific CD8+ T cells it would lead to the 
nitration of the molecules on the surface of CD8+ T cells. MDSC dependent generation of reactive 
oxygen species (ROS) and peroxynitrite causes nitration of tyrosines in the T cell receptor and CD8 
molecules, preventing the ability of T cells to respond to specific peptides. This is localized to the 
site of physical interaction between MDSC and T cells. This only involves the T cell receptor 
specific for the peptide presented by MDSCs and will not induce signalling downstream of  the T 
cell receptor. 
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Recently a group investigated the early immune responses against BCG and found an 
accumulation of MDSCs after vaccination in mice (Martino et al., 2010). Upon BCG phagocytosis, 
the MDSCs produced nitric oxide (NO). However, despite NO production, they were unable to kill 
BCG or M. smegmatis, a commonly used non-pathogenic laboratory strain. Martino et al. (2010) 
concluded that the MDSCs are propathogenic cells, cells that dampen the early T cell response 
and might play an important role in allowing BCG to persist. From this work, we can conclude that 
this population does play a very important role during tuberculosis infection and disease. 
However, their exact function during tuberculosis disease still needs to be elucidated since we 
cannot conclude that the presence of these immature cells necessarily means that they have 
immunosuppressive activity. However, side-by-side comparison of pathogen induced with cancer 
induced MDSCs are complicated by the diversity of MDSCs phenotypes elicited and to some 
extent different tumors (Van Ginderachter et al., 2010). 
 
Total dendritic cells were lower in tuberculosis patients at the end of the treatment. However, for 
the two subsets we showed that numbers increased at the end of treatment even though not 
significantly so. Furthermore, significant higher expression of the co-stimulator molecule CD40 
was seen after treatment. It is known that the capacity of M.tb stimulated T cells to produce IFN-γ 
in modulated by signalling through CD40 on APC and CD40 ligand on T cells (Samten et al., 2000). 
CD40 ligand expression is reduced in peripheral blood T cells from tuberculosis. In addition, CD40 
ligand expression increase after successful anti tuberculosis treatment and thus leads to the 
restoration of IFN-γ production (Samten et al., 2000).  
In the two different experiments, the one assessing cells before and after treatment and the one 
comparing pleural fluid and whole blood; we saw very different frequencies in mDCs and pDCs. 
The only explanation for this could be the time delay before processing the blood. In the first 
experiment blood was transported to the lab from the field sites and this resulted in a time delay 
compared to the second experiment were whole blood was taken in hospital and processed 
within the hour.  
Mendelson et al. (2006) found that patients with pleural tuberculosis have increased numbers of 
mDCs compared to healthy controls. Because we did not include healthy controls for this analysis, 
it is not possible to confirm the work by Mendelson et al. (2006). We found similar levels of mDCs 
and pDCs in diseased tuberculosis patients and their household contacts. When evaluating DC 
frequencies at the site of disease compared to circulating DCs, it was found that circulating DCs 
are higher compared to the site of disease even though not significantly so. This means that 
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during infection and disease, DCs that have taken up antigens, are moving to the lymph nodes to 
present the antigens to T cells. Therefore, similar numbers is seen circulating in tuberculosis 
patients and their household contacts and a decline is seen at site of disease when compared to 
the periphery. Again, as for MDSC, the DC frequencies were comparable to that found in cancer 
patients but during cancer circulating cells were significantly lower compared to that seen during 
tuberculosis. A high incidence of lung cancer in this population often makes it difficult to 
differentiate between lung cancer and tuberculosis (Schuurmans et al., 2007). Here we also see 
that the cells present during these diseases are very comparable. 
Strength of this work is that all cellular phenotyping were done directly ex vivo within a few hours 
of phlebotomy in order to see a realistic reflection of cell frequencies and to minimize handling 
and manipulation of cells. Sample size was limited and larger studies may show differences. 
During the follow up after treatment, only 12 patients were included due to non-compliance or 
for various other reasons. In future studies, this can be overcome by enrolling larger study groups. 
From this work, and the work of others, it is clear that the immune response against M.tb is 
complex and that interactions between the different cell types are essential to control/fight 
infection. More work should be done to look at innate cell types at different time points 
throughout treatment to better our understanding of the innate immune defence during 
tuberculosis treatment and disease. Functional studies should be performed to elucidate the role 
of MDSC during tuberculosis. Knowledge gained in the study of innate immune responses will aid 
in the diagnosis and treatment of tuberculosis and assist in vaccine development in the near 
future.  
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Chapter 6 
 
Discussion 
Introduction 
Defining correlates for protective immunity and disease susceptibility to M.tb in humans, and 
especially children, in a high tuberculosis incidence setting is not easy. IFN-γ secreted 
predominantly by adaptive immune cells is the most commonly used biomarker, which is a 
significant, but not sufficient, component of protective immunity against M.tb. As seen in the 
thesis the intricacy of the immune response against M.tb makes it apparent that other 
biomarkers are required. When investigating the immune response, the focus should be on the 
cell subsets present in a compartment and the overall cytokine microenvironment provoked by 
the presence of the cells. As soon as we have a clear picture of what occurs in different immune 
compartments, we can aim to identify biomarkers of infection and disease. The main obstacle is 
concurrent infections and as seen in this work helminths and HIV that are both predominant in 
this area lead to decreases in the protective immune response against M.tb. Here we discuss the 
most important findings from our evaluation of immune responses in of people with differential 
outcomes of M.tb exposure, as it is important to search for novel set of additional biomarkers. 
 
Summary of findings 
Cytokines patterns after acute exposure to Mycobacterium tuberculosis 
We identified the cytokines produced in 346 children and adults (ages ranging from 0 to 40 years) 
in our study setting upon stimulation with ESAT-6 and BCG (Chapter 2). No previous studies were 
reported where background and M.tb specific cytokine values were determined in a large cohort. 
Hence, the values we see for this community can be used as reference values although genetic 
and environmental factors would have to be considered when extrapolating to other populations. 
We identified biomarkers for tuberculosis infection and disease specific to this community where 
latent infection is extremely high. Biomarkers will aid in tuberculosis diagnosis and early 
determination of treatment outcome and can be used in the future in conjunction with current 
available tests to add specificity and sensitivity in tuberculosis detection in this study area. 
Previous work has been done on specific disease phenotypes in the same community .Almost half 
of the participants were TST positive and upon ESAT-6 stimulation, we found that sCD40L, IFN-γ 
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and IL-13 concentrations were higher in the TST positives compared to the TST negatives. 
However, after BCG stimulation sCD40L, IFN-γ and GM-CSF showed higher concentrations in the 
TST positive group compared to the TST negative group. Interestingly all these cytokines found to 
show differences also correlated very well with IFN-γ, leaving us to wonder if any other cytokines 
are really necessary to distinguish between these two infection groups. Other cytokine identified 
with potential diagnostic value is IL-1α and MIP-1α and it should be investigated further.One of 
the most important questions in tuberculosis pathogenesis is why some people progress to 
disease while others do not. In this investigation, we did included families from our study setting 
and retrospectively used information from the national tuberculosis register to assess outcome of 
M.tb infection in the 3 years following the study. The key finding from this investigation is the 
potentially important role of IL-10 as predictive marker for subsequent development of 
tuberculosis disease. We have identified study participants who progress to tuberculosis disease 
after the completion of the study and found a significantly higher IL-10 production in this group 
compared to those with previous tuberculosis and those who remained disease free. To our 
knowledge, this is the first study to show that even years before the progression to tuberculosis 
disease an increase in IL-10 levels is evident. Those found to progress to disease were all adults 
and hence we are still not closer to understanding why children might develop active disease. We 
conclude that the plasma IL-10 level may be suitable biomarkers for susceptibility to active 
tuberculosis in adults.  
 
Cytokine profiles in children with documented Mycobacterium 
tuberculosis exposure and infection 
In this investigation (Chapter 3) we compared the cytokine profiles in M.tb exposed and infected 
children with those who are exposed but uninfected as well as an unexposed and uninfected 
control group. Cytokine concentrations that were higher in the infected (QFT and TST positive 
group) compared to the uninfected (QFT and TST negative) were IL-2 and IP-10 at baseline and IL-
2 and IL-13 at month 6. Here we showed again that these cytokines correlate highly with IFN-γ 
and that IFN-γ correlations were similar to that found in Chapter 2. Future work should include IL-
2 in addition to IFN-γ in diagnostic assays in children. This would allow us to assess the 
importance of this cytokine in accurate identifying tuberculosis infection in children. The most 
important finding in this work is that IL-1β and IL-17 were able to differentiate between exposed 
and unexposed children. We showed significantly higher IL-1β levels at baseline in the exposed 
children compared to the unexposed however, 6 months later this difference was no longer 
apparent. This indicates that higher IL-1β and lower IL-17 production play a very important role 
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during early exposure and that this cytokine signature is associated with protection from infection 
or at least generation of adaptive immunity against M.tb. This investigation identified these 2 
cytokines that can be used in HIV uninfected children to determine recent tuberculosis exposure 
in conjunction with the exposure gradient all ready used. More studies should be performed in 
order to determine the effectiveness of these cytokines in HIV infected children.  
 
Interferon-γ responses in HIV infected and uninfected children to 
Mycobacterium tuberculosis  
In this chapter (Chapter 4), we investigated IFN-γ production in HIV infected and uninfected 
children in response to M.tb specific antigens. In addition, we compare the IFN-γ production in 
the 7 day whole blood assay compared to the overnight stimulation of the commercial QFT. HIV 
infected children have a higher risk of developing tuberculosis disease. However, very little has 
been done to investigate the effect of HIV infection on function of immune responses to specific 
mycobacterial antigens in children. Many studies now focus on the sensitivity and specificity of 
commercial IGRAs in different populations. Few studies have assessed these commercial assays in 
HIV infected children. Good correlation was found between the IFN-γ as measured by the 7 day 
whole blood assay and the IFN-γ measured by the overnight QFT. However, in the HIV infected 
participants lower IFN-γ concentrations were seen for most of the antigens tested compared to 
the HIV uninfected children. This shows that the M.tb specific immune response in the HIV 
infected children is weaker than that from healthy children. HIV infected children showed higher 
antigen specific responses after 7 day stimulation compared to the overnight stimulation in the 
QFT tubes. Clearly indicating that HIV infected children are more likely to respond to microbial 
specific antigens after 7 day stimulation. In addition, TB10.4 was found to induce higher IFN-γ 
responses in the HIV infected TST positive children. Since the ESAT-6, CFP-10 and TB7.7 antigens 
are used in commercial IGRA (QFT) the addition of TB10.4 might aid in the detection of 
tuberculosis infection in HIV infected individuals. In summary, our results suggest that detection 
of tuberculosis infection in the HIV infected children could be more sensitive when using a 7 day 
whole blood assay and in addition to the use of ESAT-6 and CFP-10, TB10.4 can be used. Future 
studies should investigate the use of TB10.4 in detecting tuberculosis infection in HIV infected 
children. With improved diagnosis of tuberculosis infection in HIV positive children, we would be 
able to target preventive therapy to tuberculosis and HIV infected children and reduce the risk of 
tuberculosis disease in these highly susceptible individuals. 
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Characterization of quantitative and functional innate immune parameters in 
Mycobacterium tuberculosis diseased adults 
Finally, innate and adaptive immune cell frequencies were evaluated before and at the end of 
tuberculosis treatment. In addition, differences between circulating and site of disease DCs and 
MDSCs frequencies were investigated. Few studies have looked at the differences in innate cell 
numbers in the peripheral blood and other compartments before and at completion of 
pulmonary tuberculosis treatment. However, compelling evidence exist indicating that the innate 
immune cells is important in the response to tuberculosis. Without a doubt, the presence of the 
MDSCs during active tuberculosis both in the peripheral blood and in pleural fluid is the important 
finding of this study. Our report is the first to show that MDSCs are present in humans during 
tuberculosis disease and that these cells decline in frequency upon tuberculosis treatment. 
MDSCs were first described during cancer and here we showed that the MDSC frequencies were 
comparable to that of cancer patients both in whole blood as well at the site of disease. Since we 
could only show the presence of these immature cells, it does not necessarily mean that they 
have immunosuppressive activity. Future studies should focus on the the molecular mechanisms 
involved in the induction of MDSCs, to characterise the mechanisms by which M.tb affects the 
expansion of MDSCs and the role of these cells in the pathogenesis of tuberculosis. It might be 
possible to use MDSCs in conjunction with other innate cell types as biomarkers to determine the 
extent of disease and to track the progress of tuberculosis treatment. More work should be done 
focusing on innate cell types throughout treatment at different time points to have better 
understand the innate immune defence during tuberculosis treatment.  
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Implications of main study findings 
Recently in a review by Barry et al. (2009) a continuous response spectrum of the outcome of 
infection with M.tb was proposed instead of the traditional binary model of latent infection and 
active disease. 
 
 
 
 
Figure 37: Spectrum of immune response to M.tb infection. Diagram adapted from Barry et al. 
(2009). 
 
 
In this model (Figure 37), there are four different outcomes for latent infection. In the first, the 
innate immune system is able to successfully control the infection and the adaptive immune cells 
are never involved. Cytokines and chemokines secreted by innate immune cells, such as 
macrophages and DCs play a crucial part in the host defence against M.tb (Russell, 2007; Cooper 
& Khader, 2008). Differential induction of these molecules could contribute to variations in 
granuloma formation, latency and active disease as discussed earlier. The inflammatory response 
of macrophages to M.tb promotes local inflammation and innate control of bacterial infection by 
macrophages, neutrophils and natural killer cells (Van CreveI et al., 2002; Korbel et al., 2008). 
When the innate immune cells are not capable of controlling the infection adaptive T cells will be 
recruited to the site of infection in order to assist in fighting the infection. It will promote the 
migration of T cells from the draining lymph node to the site of M.tb infection where they exert 
adaptive control of M.tb through granuloma formation (Cooper, 2009). Upon involvement of the 
adaptive immune cells, immunological memory would be created. In the third part of the model, 
the adaptive immune cells would not be able to eradicate the infection completely and some 
bacteria would persist but would not replicate at this point. When the immune system then fails 
to control the bacteria in this non-replicating state active infection will occur. It is then at this 
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time when the person start to present with symptoms that progression to active disease takes 
place. Within this spectrum, we will look at the main findings of this investigation as set out in 
Figure 38. 
 
  
 
 
Figure 38: Summary of main findings of this investigation within the infection spectrum. 
 
 
Effective anti-tuberculosis response starts with the host’s innate immune response and IL-1β is a 
very early component of the innate immune response against infection. We showed that during 
M.tb exposure that IL-1β levels are increased in peripheral blood. Recent studies have shown that 
activation of the IL-1β inflammasome is an important first line of defence against M.tb (Mayer-
Barber et al., 2010; Kleinnijenhuis et al., 2009). Previous reports did find IL-1β in the lungs of 
active tuberculosis patients that could be an insufficient delayed innate immune involvement. 
Therefore, we can conclude from our results that the levels of IL-1β in the exposed uninfected 
children indicates effective innate immune responses against M.tb and that the decline in IL-1β 
levels at 6 months is due to bacterial clearance. It remains to be seen what exactly is happening in 
the lungs, as site of disease, during initial exposure.  
 
As described previously it has been shown that IL-1β induced inflammation increases IL-10 
production. In our investigations, we observed that tuberculosis disease progressors have 
increased IL-10 levels up to 3 years before they were identified as active tuberculosis cases by the 
national tuberculosis treatment program. Taken into account the proposed model by Barry et al. 
(2009) we can conclude that from the stage of quiescent infection to the active disease stage can 
take any number of years. The high immune suppressive IL-10 levels measured in our study could 
have resulted from failed immune responses during the quiescent or early active stages of 
infection and may be caused by a range of genetic or environmental factors, including cytokine 
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pathway defects, helminth infection or recurrent M.tb exposure. As a delicate balance between 
pro- and anti-inflammatory responses is required during persistent but controlled infection any 
disturbance in this balance by external influences, like recurrent M.tb infection could lead to 
establishment of active disease.  
 
It is also known that MDSCs secrete IL-10 and therefore can be considered as an additional source 
of IL-10 during the onset of disease. Indeed as previously mentioned IL-1β, induced inflammation 
increases IL-10 production by MDSCs and induces MDSCs that ties in with what we have seen in 
our investigations. MDSCs may play a role in tuberculosis disease as a decline in numbers is seen 
after treatment. Since between 80 – 87 % (Constantoulakis et al., 2010) of active tuberculosis 
involves the lung the frequencies of MDSCs in the lungs becomes relevant. Although we did not 
examine MDSCs in the lung we did have an opportunity to investigate MDSCs frequencies at the 
site of disease by examining pleural effusions. However, more work must be done to compare cell 
frequencies in peripheral blood and in fluid from sites of disease, and in particular, the lung, as 
the immune response against M.tb can be compartment dependent. The question remains if 
MDSCs are involved in the pathogenesis of active tuberculosis infection or whether they are 
merely bystanders in the failed immune response against this organism. 
 
Other environmental effects 
It is known that an adaptive Th1 response is needed to control M.tb infection. Any environmental 
factor that decreases mycobacterial specific Th1 responses, including the promotion of Th2 or 
immune suppressive responses would negatively affect protection. The effect of co-infections on 
the anti-tuberculosis immune response should therefore be investigated. In this thesis, we did not 
have sufficient numbers of helminth-infected children to address the effect of helminth infection 
on anti-mycobacterial immune responses but we did show that the adaptive immune responses 
against M.tb are improved upon regular deworming. This may be due to a decrease in helminth 
induced Th2 or regulatory responses after deworming. Exposure to environmental mycobacterial 
and to high doses of M.tb is also known to induce a mixed Th1 and Th2 immune response and in 
addition, it was proposed that recurrent infections of M.tb might lead to a shift towards a Th2 
type immune response. Recurrent exposure to NTMs or M.tb in our high transmission setting may 
therefore play a role in the high tuberculosis disease incidence in our study community. 
 
As HIV mainly affect the adaptive immune system and more particularly the CD4+ T cells, it is easy 
to envisage how HIV infection can be detrimental to anti-mycobacterial immune responses. In our 
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investigations, we showed that responses to mycobacterial antigens are diminished as measured 
by QFT in HIV infected children. Nonetheless, after 7 day stimulation increased IFN-γ responses 
are seen in the same HIV infected children. From our results, we propose that after the overnight 
stimulation (QFT) mostly effector memory is measured whereas after 7 days central memory to 
M.tb is measured. Studies have shown that central memory is poorly maintained during HIV 
infection, but in children provides us with a better and hopefully more accurate M.tb infection 
determination. 
 
Future directions 
The immune response to M.tb infection is extremely dynamic. The study of multiple cytokines by 
unbiased approaches like transcriptomics or by expanded targeted approaches like the multiplex 
cytokine arrays are particularly useful to increase our understanding of the different stages of 
latent infection and disease. In addition to these assays, in vitro assays, including trans-well cell 
culture experiments can help us to elucidate the functions of different cytokines during 
tuberculosis infection and disease.  
 
Since children are more likely to be newly exposed to M.tb and as they represent a particularly 
vulnerable subpopulation the long-term follow up of children in household contact with adult 
tuberculosis cases is potentially of great value. For this purpose, the study of different protection 
phenotypes is helpful. This would provide an opportunity to investigate the contributors to the 
differential IL-1β level. Future work should focus on the role of the inflammasome during 
tuberculosis infection and disease. 
 
Analysis of innate cell types such as myeloid derived suppressor cells coupled with cytokine levels 
would allow an understanding of how cells contribute to immune suppression during tuberculosis 
disease. Since it is sometime difficult to obtain enough blood or other bodily fluids from children 
most of this work needs to be done in adults. Functional assays need to be performed to assess 
the role of important innate cells in tuberculosis pathogenesis. Together, this will lead to a more 
comprehensive picture of the host innate immune response during infection. The information 
obtained through these future studies would be invaluable for future vaccination experiments. 
 
All investigations need to be expanded to include approaches like transcriptomic (including deep 
sequencing, which also allows the evaluation of micro RNA and splice variants of immune 
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molecules), metabolomics and proteomics to enable a comprehensive delineation of protective 
and non-protective anti-mycobacterial responses. 
 
Conclusion 
The immune response against M.tb is complex. Interactions between different cell types are 
essential to control M.tb exposure, infection and disease. In this thesis, we present new 
biomarkers that play important roles during the different stages of M.tb pathogenesis along the 
continuum of exposure, infection and disease. These may shed light on mechanisms of protection 
against M.tb, relevant to development of tuberculosis diagnostics and vaccine strategies. 
Combinations of multiple biomarkers including cytokines and chemokines and cell subsets are 
required to characterise biosignatures relevant to the diagnosis of tuberculosis infection and 
disease.  
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Annexure 1 
 
The following supportive data is included in this annexure. 
1. Comparison of age vs TST results. One way ANOVA test of variance in the whole study 
group.  
2. Comparison of age vs TST results. One way ANOVA test of variance in children under 16 
years of age (as some studies performed only included younger children). 
3. Comparative plots of IL-1α (log value) in study groups as described in Chapter 3. IL-1α was 
chosen as a representative for all other cytokines.  
4. FMO plots for CD33 vs CD11b for the identification of MDSCs. 
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1. Comparison of age vs TST results. One way ANOVA test of variance in the whole study 
group.  
This analysis was performed to confirm that TST positivity is not associated with recent 
BCG vaccination. Results indicate that a positive TST is associated with older age. 
  
TST result; LS Means
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2. Comparison of age vs TST results. One way ANOVA test of variance in children under 16 
years of age (as some studies performed only included younger children). 
  
TST result; LS Means
Current effect: F(2, 219)=17.384, p=<0.01 Kruskal-Wallis p<0.01
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Vertical bars denote 0.95 confidence intervals
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3. Comparative plots of IL-1α (log value) in study groups as described in chapter 3. IL-1α 
was chosen as a representative for all other cytokines.  
The first plot show results without adjusting for age. In the second plot age was 
included as a covariate and results did not change. 
  
group; LS Means
Current effect: F(2, 41)=8.8486, p=.00064
(Computed for covariates at their means)
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4. FMO plots for CD33 vs Cd11b for the identification of MDSCs. 
In the first plot the FMO control for CD33 is shown. Gate was set in order to determine 
the cut off between CD33 negative and positive (horizontal line). In the second plot the 
FMO control for CD11b is shown. Gate was set to determine the cut off between CD11b 
negative and positive (vertical line). The gating strategy was employed in the analysis of 
MDSCs.  
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Annexure 2 
 
The next pages are examples of the case report form, laboratory form and treatment outcome 
forms as used for the work as presented in Chapter 5. The mail merge function was used to insert 
participant numbers on the forms as recorded in the Excel database. All participant numbers are 
indicated by XXX on the forms in this example. 
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  Follow up date: 
 
  1. Personal Information 
  1.1 Date of Birth 
  1.2 Gender 
 
  2. TB Treatment 
  2.1 When was TB treatment started? 
  2.2 Was TB treatment successfully completed? 
  2.3 If yes, when was TB treatment completed? 
 
  3. Culture Results  
  Month 2 culture: 
  3.1 Please indicate smear/culture results 
  End of treatment culture: 
  3.2 Please indicate smear/culture results 
  
TB Treatment Response Study 
Month 6 Case Report Form 
January 2010—June 2010  
  
Patient recruitment ID: Rxxx                                    Follow up ID: F6-xxx  
DD/MM/YYYY 
DD/MM/YYYY 
Y N 
M F 
Pos
 
Neg Unknow
n 
DD/MM/YYYY 
Pos
 
Neg Unknow 
DD/MM/YYYY 
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TB Treatment Response Study 
Month 6 Lab Form 
January 2010—June 2010 
   
Patient recruitment ID:  Rxxxx 
Follow up ID:   F6-xxx 
  
 
To be completed by study nurse: 
 
 Date blood taken   
  
 Time blood taken at clinic              
  
  
 
 Time received in lab 
      
Time PBMC isolation start 
Blood tubes collected: 
NaHep volume   
NaHep volume 
NaHep volume 
NaHep volume 
PaxGene volume 
EDTA volume 
Sputum 
ID on tubes and sputum pot should be «F6-xxx» 
DD/MM/YYYY 
H 
H 
H 
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Followed up time frame: «1 week before» - «Follow up 2010» 
Is the patient followed up within the time frame? 
If no, please give reason and date of follow up:............................................................... 
Please choose an outcome for patient: 
1 Cured patient: a patient whose sputum smear is negative in the last month of 
treatment 
2 Treatment completed: treatment period completed but criteria for cure or failure 
are not met due to contaminated smear or as no smear was done 
3 Failed treatment: smear becomes positive again or remains positive at or after 
month 5 of treatment 
 4 Not treated: less than 10 dosages TB treatment taken 
5 Defaulter: a patient who does not adhere to treatment regimen for at least 2 
consecutive months 
6 Transferred out: transferred while on treatment to another reporting or recording 
unit, where treatment is continued but outcome is unknown 
 7 Death while on TB treatment: any death, not necessarily from TB 
 8 Missed visit: missed visit with study nurse 
In the case of a missed visit please obtain the outcome from the TB clinic records and 
note here: ........................................................................................................................  
  
Nurse initials: ................................................. 
TB Treatment Response Study 
Month 6 Outcome 
January 2010—June 2010 
   
Patient recruitment ID:   Rxxxx 
Follow up ID:   F6-xxx 
Y N 
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